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Histones undergo different types of post-translational modifications that have been linked
to a variety of biological processes and disease states. Histone acetylation and
methylation are well characterized modifications with respect to regulation of chromatin
structure and transcription. Histone acetylation, regulated by histone acetyltransferases
(HATs) and histone deacetylases (HDACs), is linked with gene activation. Here we
introduce a novel paradigm suggesting that holocarboxylase synthetase (HLCS), the sole
biotin protein ligase in the human genome, recruits nuclear receptor corepressor (N-CoR)
and HDAC1 to chromatin, thereby contributing toward the removal of lysine (K)-9
acetylated histone H3 (H3K9ac) gene activation marks and the repression of repeats,
linking biotin metabolism with histone acetylation. We observed that (1) HLCS interacts
physically with N-CoR and HDAC1; (2) HLCS overexpression induces a significant
decrease in the abundance of H3K9ac marks in long terminal repeats (LTRs) 15 and 22
decreasing LTR expression; and (3) HLCS-dependent repression of pericentromeric

alpha satellite repeats. We conclude that interactions of HLCS with N-CoR and HDAC1
contribute toward transcriptional repression of repeats. Unlike histone acetylation,
histone methylation is commonly associated with either transcriptional activation or
repression and is regulated by the opposing activities of histone methyltransferases and
demethylases. Lysine specific demethylase 1 (LSD1) is a flavin adenine dinucleotide
(FAD)-dependent demethylase that catalyzes the removal of methyl groups from lysine-4
in histone H3 (H3K4me1, H3K4me2), thereby mediating gene repression. We cultured
cells in riboflavin-defined media providing riboflavin at levels representing moderately
deficient, sufficient, and supplemented in humans. LSD1 activity depends on the
concentrations of the FAD precursor, riboflavin, in cell culture media, and riboflavin
deficiency causes de-repression of albumin and pro-inflammatory cytokines in human
HepG2 and Jurkat cells, respectively. Loss of LSD1 activity is associated with a
significant increase in the abundance of H3K4me2 marks, leading to an aberrant upregulation of target gene expression. In conclusion, riboflavin affects gene regulation by
epigenetic mechanisms, mediated by a loss of LSD1 activity.
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INTRODUCTION
Eukaryotic cells contain largely identical genetic information encoded in DNA. However,
cells with identical genomes have widely different gene expression patterns in different
organs and tissues, which need to respond to developmental and environmental changes.
In eukaryotes, the chromatin state, the packaging of DNA with histone proteins, is
believed to contribute to the control of gene expression (Jenuwein and Allis, 2001; Greer
and Shi, 2012). Since the early 1960s, it has been know that histones are posttranslationally modified (Allfrey et al., 1964). Histones are subject to a wide variety of
post-translational modifications, including but not limited to, lysine acetylation, lysine
and arginine methylation, serine and threonine phosphorylation, and lysine ubiquitination
and sumoylation (Vaquero et al., 2003; Tan et al., 2011). These modifications occur
primarily within the histone amino-terminal tails protruding from the surface of the
nucleosome as well as on the globular core region (Cosgrove et al., 2004). Histone
modifications are thought to contribute to the control of gene expression not only through
regulating chromatin structure by merely being there, but also recruiting remodeling
enzymes that utilize the energy derived from the hydrolysis of ATP to reposition
nucleosomes. The recruitment of proteins and complexes with specific enzymatic
activities is now an accepted dogma of how modifications mediate their function (Strahl
and Allis, 2000; Bannister and Kouzarides, 2011).
Histone acetylation, first discovered in 1964 (Allfrey et al., 1964), is a dynamic posttranslational modification regulated by the opposing activities of histone
acetyltransferases (HATs) and histone deacetylases (HDACs) (Shahbazian and Grunstein,
2007). Aacetylation catalyzed by HATs usually marks transcriptionally active genes, as it
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contributes to the decondensed chromatin state and maintains the unfolded structure of
the transcribed nucleosome (Tse et al., 1998; Wang et al., 2001; Shogren-Knaak et al.,
2006; Shahbazian and Grunstein, 2007; Davie et al., 2008). In contrast, HDACs are found
in corepressor complexes catalyzing deacetylation of histones, leading to the formation
of a compacted, transcriptionally repressed chromatin structure (Yang and Seto, 2007).
To date, eighteen different mammalian HDACs have been identified and divided into
four classes based on their sequence similarity to yeast counterparts. HDACs from the
classical family are dependent on Zn2+ for deacetylase activity and constitute classes I, II
and IV. Classes I and II contain enzymes that are most closely related to yeast scRpd3
and scHda1, respectively. Class IV has only a single member, HDAC11, while class III
(sirtuins) are homologous to yeast scSir2. Class III HDACs, in contrast to the other three
classes, requires a specific cofactor, NAD+, for catalytic activity (de Ruijter et al., 2003;
Gregoretti et al., 2004; Yang and Seto, 2007).
In general, HDACs have relatively low substrate specificity if operating independently of
other proteins, and may deacetylate multiple lysine residues in histones. HDACs are
typically present in multiple distinct complexes. For instance, HDAC1 is found together
with HDAC2 in multiprotein corepressor complexes Sin3, nucleosome-remodeling
HDAC (NuRD) and CoREST, which are recruited to chromatin regulatory regions by
transcription factors and play very diverse, often cell-specific, roles (de Ruijter et al.,
2003; Yang and Seto, 2008; Patel et al., 2011). The interactions among these proteins in a
complex likely determine the overall activity, substrate specificity and genomic location
of the multiprotein complex. Of note, HDAC1 and HDAC2 also interact with nuclear
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receptor corepressor (N-CoR) through the most N-terminal of N-CoR repression domain
via the Sin3 corepressor (Alland et al., 1997; Heinzel et al., 1997; Nagy et al., 1997).
Histone methylation, mainly occurring on the side chains of lysines (K) and arginines (R),
has a long half-life compared to other histone modifications (Barth and Imhof, 2010).
Unlike histone acetylation, which is always associated with transcriptional activation
(Grunstein, 1997), histone methylation can be involved in either transcriptional activation
or repression. For example, K4-dimethylated histone H3 (H3K4me2) is an active mark
for transcription. In contrast, K9-trimethylated histone H3 (H3K9me3) is linked to
transcriptional repression (Allis et al., 2007; Kouzarides, 2007). Histone methylation,
catalyzed by histone methyltransferases (Petrossian and Clarke, 2011), was originally
thought to be relatively permanent and irreversible (Byvoet et al., 1972). That paradigm
changed with the discovery of the first histone demethylase, lysine specific demethylase
1 (LSD1; also known as KDM1A, BHC110 and AOF2). It is now widely accepted that
histone methylation is, in fact, reversible (Shi et al., 2004). Both histone
methyltransferases and demethylases have central roles in various cell biological
processes, including regulation of chromatin structure and transcription; they are also
important for normal development and are involved in diseases such as cancer (Pedersen
and Helin, 2010; Duncan and Allis, 2011; Yoshimi and Kurokawa, 2011). Genetic studies
have shown that deletion or mutation of several different demethylases lead to
developmental defects (Pedersen and Helin, 2010). For example, deletion or mutation of
LSD1 homologues in Drosophila melanogaster and Caenorhabiditis elegans affects the
germ line and fertility in both organisms (Di Stefano et al., 2007; Katz et al., 2009;
Eliazer et al., 2011).
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LSD1 catalyzes the removal of methyl groups from K4-monomethylated histone H3
(H3K4me1) and H3K4me2 via a flavin adenosine dinucleotide (FAD)-monoamine
oxidase mechanism (Shi et al., 2004; Forneris et al., 2005; Lee et al., 2005; Rudolph et al.,
2007). Consistent with the H3K4me1/2 activation mark as a substrate, LSD1 is found in
cells as part of a complex with the co-repressor, CoREST and HDAC1/2 (Humphrey et
al., 2001; You et al., 2001; Hakimi et al., 2002), which represses transcription by
deacetylating histone tails. Besides these canonical functions, LSD1 has also been
identified as a component of NuRD complex, via interaction of the Tower domain with
metastasis tumor antigen 1-3 in breast cancer cells (Wang et al., 2009). Interestingly, the
demethylase specificity and activity of LSD1 appear to be determined by its binding
partners. When associated with the androgen receptor, LSD1 switch its substrate
specificity from H3K4me1/2 to H3K9me1/2 (Metzger et al., 2005; Wissmann et al.,
2007), consistent with a role in gene activation (Garcia-Bassets et al., 2007). Thus, the
composition of LSD1-containing complexes has the potential to alter the substrate
specificity.
This introduction will focus on the regulation of gene expression through histone
modifications from the following two perspectives: one is the role of K9-acetylated
histone H3 (H3K9ac) marks in the repression of repeats, as mediated by physical
interactions between holocarboxylase synthetase (HLCS) and N-CoR and HDAC1; the
other is the role of H3K4me2 marks in the expression of target genes, mediated by the
FAD-dependent LSD1 in cell cultures.
HLCS represses gene expression through a multi-protein complex
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Biotin is a water-soluble vitamin that serves as a covalently bound coenzyme for five
carboxylases (Zempleni et al., 2012b). HLCS catalyzes the binding of biotin to all five
carboxylases and, therefore, plays a pivotal role in biotin-dependent metabolic pathways
(Suzuki et al., 1994; Zempleni et al., 2012b). Recently, it was demonstrated that HLCS
participates in gene regulation at the chromatin level, i.e., full-length HLCS and a
splicing variant enter the nuclear compartment and bind to chromosomes in a locusspecific, punctuate pattern (Camporeale et al., 2006b; Singh et al., 2011). Evidence
suggests that HLCS also has histone-biotin ligase activity (Kobza et al., 2008; Bao et al.,
2010), catalyzing the covalent binding of biotin to distinct lysine residues in histones
(H2A, H3, and H4), and HLCS knock-down leads to a loss of biotinylation marks on
histones (Camporeale et al., 2004; Kobza et al., 2005; Chew et al., 2006; Chew et al.,
2008; Bao et al., 2011; Pestinger et al., 2011; Rios-Avila et al., 2012).
Consistent with the important roles of HLCS in intermediary metabolism, no living
HLCS null individual has ever been reported, suggesting embryonic lethality. Mutations
of human HLCS gene have been identified and characterized, which cause a substantial
decrease in HLCS activity and metabolic abnormalities (Suzuki et al., 2005). HLCS
knockdown results in severe phenotypes such as short life span and low heat stress
resistance in Drosophila melanogaster and chromosomal abnormalities in human cell
cultures (Camporeale et al., 2006a; Chew et al., 2008).
Recently, a coherent model has been established, which implicates HLCS in gene
repression through epigenetic mechanisms (Fig. 1). In this model, HLCS locates to the
chromatin through physical interactions with DNA methyltransferase 1 and methyl CpG
binding protein 2 (Xue et al., 2013) and this chromatin-bound HLCS further recruits
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eukaryotic histone H3 methyltransferase 1 (EHMT-1) , which creates abundant K9dimethylated histone H3 (H3K9me2) repression marks and mediates repression (Li et al.,
2013). According to this model, histone biotinylation is considered as mere marks for
HLCS docking sites in chromatin and is caused by the close physical proximity between
HLCS and histones (Bao et al., 2011). Notably, histone biotinylation is a comparably rare
modification, only less than 0.001% of histones H3 and H4 being biotinylated in human
chromatin (Stanley et al., 2001; Bailey et al., 2008; Kuroishi et al., 2011). However, the
abundance of an epigenetic mark is not the measure for its importance and this novel
model may explain the controversies between the rarity of histone biotinylation and its
significance in metabolism.

Figure 1 HLCS-containing multi-protein gene repression complex.
DNA methylation in the genome is maintained by DNMT1, which recruits MeCP2 to
bind to methylated CpG. HLCS locates to the same loci through physical interactions
with MeCP2 and DNMT1, and further recruits EHMT1, N-CoR, and HDACs.
Abbreviations: ac, acetyl; bio, biotin; DNMT1, DNA methyl transferase 1; HP1,
heterochromatin protein 1; MBD, methyl-binding domain proteins; me, methyl; MeCP2,
methyl-CpG-binding protein 2 (Liu, et al., unpublished).
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Biotinylation marks have been linked to gene repression due to the fact that they are
enriched in repressed genomic loci and found to co-localize with the repressive histone
methylation marks (Camporeale et al., 2007; Chew et al., 2008; Gralla et al., 2008;
Wijeratne et al., 2010; Pestinger et al., 2011; Rios-Avila et al., 2012; Li et al., 2013). For
example, K12-biotinylated histone H4 (H4K12bio) is a mark for repeat regions and
heterochromatin, plays a role in gene repression, and co-localizes with the repression
mark H3K9me2 (Camporeale et al., 2007). Furthermore, the correlation between histone
biotinylation and the repression of long terminal repeats (LTRs) in the human genome
has been reported in previous studies (Zempleni et al., 2009). Chromatin
immunoprecipitation assays provided evidence that H4K12bio is greatly enriched at loci
coding for both intact and solitary LTRs in a human lymphoid cell line. Similar
observations were made in human and mouse cell lines that originated in other tissues
(Chew et al., 2008). HLCS dysfunction caused by genetic deficiency was correlated with
increased transcription level of LTRs (Chew et al., 2008). These observations have
substantial biological importance because transcription of LTRs is the first and critical
step in retrotransposition events, which further increase the rates for spontaneous
mutations in the genome (Kazazian, 2004; Martens et al., 2005; Kovalskaya et al., 2006;
Slotkin and Martienssen, 2007; Zempleni et al., 2009). A great variety of human diseases
have been linked to retrotranspositions in the genome, including breast cancer and colon
cancer (Kazazian et al., 1988; Morse et al., 1988; Miki et al., 1992).
LSD1 regulates gene expression depending on riboflavin supply
Riboflavin, a water-soluble vitamin, is a precursor of FAD and flavin mononucleotide
(FMN), which function as coenzymes for redox reactions in numerous metabolic

8

pathways and in energy production (Rivlin, 1986; Rivlin, 2001). The redox reactions in
which flavocoenzymes participate include flavoprotein-catalyzed dehydrogenations,
reactions with sulfur-containing compounds, hydroxylations, oxidative decarboxylations,
dioxygenations, and reduction of oxygen to hydrogen peroxide (National, 1998).
Riboflavin metabolism begins with the adenosine triphosphate-dependent
phosphorylation of riboflavin to FMN. FMN can then be complexed with specific
apoenzymes to form a variety of flavoproteins; however, most FMN is converted to FAD
and the latter is the predominant flavocoenzyme in body tissues (National, 1998).
Maternal intake of riboflavin has been shown to correlate positively with fetal growth and
development (Badart-Smook et al., 1997). Animal studies suggest that riboflavin
deficiency during pregnancy leads to congenital abnormalities (Rivlin, 1975). The signs
of riboflavin deficiency in humans include sore throat, hyperemia of oral mucous
membranes, normocytic anemia associated with pure erythrocyte cytoplasia of the bone
marrow, and other physical symptoms (Powers, 2003). Severe riboflavin deficiency may
impair the metabolism of vitamin B6 by limiting the amount of FMN required by
pyridoxine 5-phosphate oxidase and the conversion of tryptophan to functional forms of
niacin (McCormick, 1989).
Previous studies in cell models suggested that riboflavin deficiency impairs the oxidative
folding and secretion of interleukin (IL)-2 in human T lymphoma Jurkat cells, as well as
secretion of apolipoprotein B-100 in HepG2 human hepatocarcinoma cells (Camporeale
and Zempleni, 2003; Manthey et al., 2005). In addition, riboflavin deficiency has been
correlated to oxidative damage to proteins and DNA in HepG2 cells (Manthey et al.,
2006).
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It is widely recognized that nutritional factor play a role in methylation events, although
the majority of previous studies focused on methyl donors (Zempleni et al., 2012a).
LSD1, known as the first reported histone demethylase, is unique among numerous
histone demethylases due to its dependence on FAD (Forneris et al., 2005). To date, there
is no published research focusing on the effects of riboflavin supply on LSD1
demethylase activity. This knowledge gap caused concern since riboflavin deficiency
could be caused by multiple factors, such as genetic abnormalities, thyroid hormone
insufficiency, alcohol consumption, and consumption of certain drugs, e.g., tricyclic and
tetracyclic compounds (Pinto et al., 1981; Cimino et al., 1987; Pinto et al., 1987; Dutta et
al., 1988; Horvath, 2012).
Conclusion
Histone modifications, believed to be implicated in the epigenetic regulation of gene
expression, are not only affected by the synergized chromatin proteins, but also impacted
by the supply of nutrients. The following chapters will provide in-depth investigations of
the underlying mechanism of the (i) HLCS-containing protein complex in repression of
repeats; (ii) FAD-dependent LSD1 activity and target gene expression, and (iii) FADdependent LSD1 in the regulation of pro-inflammatory cytokine expression.
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Abstract
Holocarboxylase synthetase (HLCS) is a nuclear protein that catalyzes the binding of
biotin to distinct lysine residues in chromatin proteins. HLCS-dependent epigenetic
marks are overrepresented in repressed genomic loci, particularly in repeats. Evidence is
mounting that HLCS is a member of a multi-protein gene repression complex, which
determines its localization in chromatin. Here we tested the hypothesis that HLCS
interacts physically with nuclear receptor corepressor (N-CoR) and histone deacetylase 1
(HDAC1), thereby contributing toward the removal of lysine-9 acetylated histone H3
(H3K9ac) gene activation marks and the repression of repeats. Physical interactions
between HLCS and N-CoR, HDAC1, and a novel splicing variant of HDAC1 were
confirmed by co-immunoprecipitation, limited proteolysis, and split luciferase
complementation assays. When HLCS was overexpressed, the abundance of H3K9ac
marks decreased by 50% and 68% in long terminal repeats (LTRs) 15 and 22,
respectively, in human embryonic kidney HEK293 cells compared with controls. This
loss of H3K9ac marks was linked with an 83% decrease in mRNA coding for LTRs.
Similar patterns were seen in pericentromeric alpha satellite repeats in chromosomes 1
and 4. We conclude that interactions of HLCS with N-CoR and HDACs contribute
toward the transcriptional repression of repeats, presumably increasing genome stability.

Key Words: chromatin; epigenetics; gene repression; holocarboxylase synthetase; histone
deacetylase 1; nuclear receptor corepressor
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Introduction
Holocarboxylase synthetase (HLCS) is the sole biotin protein ligase in the human
genome (Suzuki et al., 1994). Historically, HLCS was appreciated for its role in attaching
biotin to distinct lysine residues in five human carboxylases, which catalyze essential
steps in fatty acid metabolism, gluconeogenesis, and leucine metabolism in cytoplasm
and mitochondria (Zempleni et al., 2012). Recently, it was demonstrated that full-length
HLCS and a splicing variant also enter the nuclear compartment and that nuclear HLCS
binds to chromosomes in a locus-specific, punctuate pattern (Camporeale et al., 2006b;
Singh et al., 2011). These observations implicate HLCS in gene regulation. Unambiguous
evidence suggests that HLCS has histone-biotin ligase activity (Kobza et al., 2008; Bao et
al., 2010), catalyzing the binding of biotin to distinct lysine residues in histones
(Camporeale et al., 2004; Kobza et al., 2005; Chew et al., 2006). HLCS-dependent
histone biotinylation marks are enriched in repressed genomic loci (Camporeale et al.,
2007a; Chew et al., 2008; Gralla et al., 2008; Wijeratne et al., 2010; Pestinger et al.,
2011; Rios-Avila et al., 2012), consistent with a role of HLCS in gene repression. Note
that only less than 0.001% of histones H3 and H4 are biotinylated in human chromatin
(Stanley et al., 2001; Bailey et al., 2008; Kuroishi et al., 2011). Because of the rarity of
biotinylation marks, it is unlikely that histone biotinylation per se is responsible for
causing the repression of genes and severe phenotypes of HLCS knockdown such as
short life span and low heat stress resistance in Drosophila melanogaster and
chromosomal abnormalities in human cell cultures (Camporeale et al., 2006a; Chew et al.,
2008). Moreover, HLCS does not contain a classical nuclear localization signal or a
DNA-binding motif that would explain its nuclear localization and binding to
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chromosomes. Evidence suggest that the binding of HLCS to chromosomes and perhaps
its nuclear entry might be facilitated by physical interactions with histone H3 (Bao et al.,
2011), but these interactions do not explain the punctuate distribution of HLCS in
chromatin (Camporeale et al., 2006b; Singh et al., 2011).
Recently, we have integrated the above reports into a coherent model that implicates
HLCS in gene repression through epigenetic mechanisms (Fig. 1). According to this
model, HLCS is recruited to chromatin through physical interactions with the
maintenance DNA methyltransferase DNMT1 and the methyl CpG binding protein 2,
MeCP2 (Xue et al., 2013), consistent with previous observations that erasure of DNA
methylation marks impairs HLCS-dependent biotinylation events in chromatin (Chew et
al., 2008). Also according to this model, chromatin-bound HLCS recruits the eukaryotic
histone H3 methyltransferase EHMT-1, which creates abundant lysine-9 methylated
histone H3(H3K9me) gene repression marks; the physical interaction between HLCS and
EHMT-1 appears to be strengthened by HLCS-dependent biotinylation of lysine-161 in
EHMT-1 (Li et al., 2013). Consistent a role of HLCS in the formation of a multi-protein
gene repression complex, the abundance of H3K9me marks in repeats is severely reduced
in HLCS knockdown models (Chew et al., 2008; Pestinger et al., 2011). Histone
biotinylation marks are mere marks for HLCS docking sites in chromatin and are caused
by the close physical proximity between HLCS and histones (Bao et al., 2011).
The discovery of the interactions between HLCS and EHMT-1 was initiated by
developing a protocol for predicting HLCS-binding proteins in silico (Li et al., 2013).
Note that the protocol also predicted that HLCS interacts with N-CoR, a protein known to
facilitate the binding of HDACs in chromatin (Alland et al., 1997; Heinzel et al., 1997;
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Nagy et al., 1997). HDACs play crucial roles in gene repression, mediated by HDACdependent removal of histone acetylation marks (Kouzarides and Berger, 2007). Here we
tested the hypotheses that HLCS interacts with N-CoR and HDAC1 and that these
interactions play roles in the repression of repeats.

Results
In silico predictions
In silico predictions suggested that the GGGG(K/R)G(I/M)R sequence in N-CoR is a
candidate for mediating physical interactions with HLCS and that, because of the known
interactions between N-CoR and HDAC1, the latter might also be a candidate for
interacting physically with HLCS. N-CoR had score of 17.2 bits and an E value of 393,
compared with scores of 20.2 bits and 16.3 bits and E values of 57 and 634 for the
HLCS-interacting proteins propionyl-CoA carboxylase and EHMT-1, respectively.
Interaction between HLCS and N-CoR
HLCS interacts with the C-terminus in N-CoR, based on the following lines of evidence.
HEK293 cells were co-transfected with plasmid pCMV-Myc-HLCS and plasmids coding
for the three N-CoR fragments, i.e., pCMV-HA-N-CoR-NT, pCMV-HA-N-CoR-CD, or
pCMV-HA-N-CoR-CT. When cell lysates were precipitated with anti-Myc and probed
with anti-HA, a distinct signal was obtained only for cells transfected with the plasmid
coding for the N-CoR C-terminus, pCMV-HA-N-CoR-CT (Fig. 3A, upper gel), but not
for those transfected with pCMV-HA-N-CoR-NT and pCMV-HA-N-CoR-CD (data not
shown). The same pattern was seen when cell lysates were precipitated with anti-HA and
probed with anti-HLCS (Fig. 3A, lower gel, and data not shown). Empty vectors in
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various permutations and non-transfected cells produced no detectable signal (negative
controls). Next, tags were swapped and HEK293 cells were co-transfected with pCMVHA-HLCS and either pCMV-Myc-N-CoR-NT, pCMV-Myc-N-CoR-CD, or pCMV-MycN-CoR-CT. Again, only cells co-transfected with HLCS and the plasmid coding for the
N-CoR C-terminus, pCMV-HA-N-CoR-CT, produced distinct signals in coimmunoprecipitation assays; no signal was produced by negative controls (Fig. 3B, upper
and lower gels) and by cells co-transfected with HLCS and plasmids coding for the Nterminus and central domain in N-CoR (data not shown).
Previous studies suggest that lysine residues in HLCS-binding motifs are important for
HLCS binding (Li et al., 2013). The predicted motif in N-CoR includes K2323 and
K2325 in full-length N-CoR. When HEK293 cells were co-transfected with plasmid
pCMV-HA-HLCS and plasmids coding for the wild-type C-terminus in N-CoR (pCMVMyc-N-CoR-CT), the K2323 mutant (pCMV-Myc-N-CoR-CTK2323R), the K2325 mutant
(pCMV-Myc-N-CoR-CTK2325R), or the deletion construct (pCMV-Myc-N-CoR-CTdel),
meaningful signals were detected only for the wild-type N-CoR and the K2323 mutant,
suggesting that K2325 and the HLCS-binding motif are essential for mediating
interactions with HLCS (Fig. 3C, upper gel). The same pattern was seen when cell lysates
were precipitated with anti-HA and probed with anti-Myc (Fig. 3C, lower gel).
Limited proteolysis assays were conducted using recombinant proteins. When
recombinant HLCS and the C-terminal fragment of N-CoR were incubated with trypsin
in the absence of putative binding partners, both proteins degraded completely within 10
min of incubation (Fig. 3D, upper and middle gels). In contrast, when recombinant HLCS
was pre-incubated with the N-CoR C-terminal fragment prior to trypsin treatment, the
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proteolytic degradation of both HLCS and N-CoR was substantially delayed compared
with the individual proteins, and strong protein signals were detectable after 30 min of
incubation with trypsin (Fig. 3D, lower gel). When recombinant HLCS was pre-incubated
with N-CoR N-terminus and central domain, tryptic digestion of the proteins was not
delayed (data not shown). Note that the molecular weights of recombinant HLCS (~81
kDa) and the N-CoR C-terminus (~82 kDa) are similar, making it difficult to distinguish
the two proteins at early time points of incubation (≤20 min), when protein
concentrations are high.
Split luciferase complementation assays were conducted to confirm the interactions
between HLCS and N-CoR fragments. When co-expressed in HEK293 cells, constructs
HLCS-NLuc and N-CoR-CT-CLuc produced a strong chemiluminescence signal,
whereas N-CoR-NT-CLuc and N-CoR-CD-CLuc produced a signal that was equivalent
to the background signal produced by co-expressing N- and C-terminal fragements of
luciferase not fused to protein (Fig. 4). Positive control (TP53-NLuc plus MDM2-CLuc)
and negative control (TP53-NLuc plus CDK3-CLuc) produced the expected results.
Specifically, the signal produced by co-expression of constructs HLCS-NLuc and NCoR-CT-CLuc was about 3.7 times the signal produced by cells that were co-transfected
with unfused NLuc and CLuc fragments (background control for self-association) and
about 3.1 times the signal produced by cells transfected with TP53-NLuc and CDK3CLuc.
Interactions between HLCS and HDAC1s
HLCS interacts physically with full-length HDAC1 and the novel splicing variant
HDAC1Δ31, based on the following lines of evidence. HEK293 cells were co-transfected
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with pCMV-Myc-HLCS and either pCMV-HA-HDAC1 or pCMV-HA-HDAC1Δ31.
When cell lysates were precipitated with anti-Myc and probed with anti-HDAC1
(Abcam), distinct signals were obtained for both HDAC1 and HDAC1Δ31 (Fig. 5A,
upper gel). Likewise, when cell lysates were precipitated with anti-HA and probed with
anti-HLCS, distinct signals were obtained for HLCS (Fig. 5A, lower gel). Empty vectors
in various permutations and non-transfected cells produced no detectable signal (negative
controls). Next, tags were swapped and HEK293 cells were co-transfected with pCMVHA-HLCS and either pCMV-Myc-HDAC1 or pCMV-Myc-HDAC1Δ31. Again, only
cells co-transfected with HLCS and HDAC1 or HDAC1Δ31produced distinct signals,
whereas no signal was produced by negative controls (Fig. 5B, upper and lower gels).
Limited proteolysis assays were conducted with recombinant HLCS and HDAC1s.
Recombinant HLCS was degraded within 10 min of incubation with trypsin, if no
HDAC1s was added to the sample. Similarly, HDAC1 and HDAC1Δ31 were completely
degraded within 20 min of trypsin treatment, if no HLCS was present (Fig. 5C, left gels).
When recombinant HLCS was pre-incubated with either HDAC1 or HDAC1Δ31 before
trypsin treatment, the proteolytic degradation of both HDAC1s was substantially delayed
compared with the individual treatments, and strong protein signals were detectable even
after 30 min of incubation with trypsin (Fig. 5C, middle and right gels). The proteolytic
degradation of HLCS was not delayed in samples containing HDAC1s (see Discussion).
Split luciferase complementation assays confirmed that HLCS interacts with HDAC1s.
HEK293 cells were co-transfected with constructs HLCS-NLuc and either HDAC1-CLuc
or HDAC1Δ31-CLuc. Co-expression resulted in a strong chemiluminescence signal for
both HDAC constructs, which was significantly higher than that of controls (Fig. 6). The
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signal was about 2.9 times the signal produced by cells that were co-transfected with
unfused NLuc and CLuc fragments (background control for self-association) and about
2.4 times the signal produced by cells transfected with TP53-NLuc and CDK3-CLuc
(negative control).
The roles of HLCS domains in mediating interactions with N-CoR and HDAC1s
The N-terminus in HLCS is essential for mediating physical interactions with N-CoR and
HDAC1s. HEK293 cells were co-transfected with pCMV-Myc constructs coding for the
four known HLCS domains (Hassan et al., 2009a) and either pCMV-HA-N-CoR-CT,
pCMV-HA-HDAC1, or pCMV-HA-HDAC1Δ31. When cell lysates were precipitated
with anti-Myc and probed with anti-HA, distinct signals were obtained only for cells cotransfected with pCMV-Myc-HLCS-NT and the N-CoR C-terminus or HDAC1
constructs, but not for cells in which HLCS domains other than the N-terminus were
overexpressed and also not for the various negative controls (Fig. 7A,B).
HLCS-dependent biotinylation of N-CoR and HDAC1s
Recombinant HLCS biotinylates recombinant N-CoR and HDAC1s in vitro, consistent
with the promiscuous nature of HLCS and its microbial ortholog BirA {(Kobza et al.,
2008; Bao et al., 2011; Li et al., 2013); see Discussion]}. When recombinant HLCS was
incubated with recombinant N-CoR N-terminus, central domain, and C-terminus for 2 h,
protein-bound biotin was detected in the N-CoR C-terminus (Fig. 8A, lower gels) but too
a much lesser extent in the other domains of N-CoR (upper gels) using anti-biotin as
probe. When recombinant HLCS was incubated with HDAC1 or HDAC1Δ31 for 2 h,
protein-bound biotin was detected in both HDAC1 and HDAC1Δ31 (Fig. 8B). Negative
controls were created by omitting HLCS, N-CoR, or HDAC1s in biotinylation assays; the
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negative produced biotin signals that were negligible or not detectable. Equal loading was
confirmed using coomassie blue.
Transcriptional regulation of repeats by HLCS
The abundance of H3K9ac marks in repeats depended on HLCS in HEK293 cells. HLCS
was overexpressed using plasmid p3XFLAG-Myc-CMV-26-HLCS (Xue et al., 2013) and
the efficacy of HLCS overexpression was assessed using mRNA and protein levels. The
abundance of mRNA coding for HLCS was about 49 times greater in overexpression
cells compared with non-transfected controls; the increase in protein abundance was
equally compelling (Fig. 9A and insert). While HLCS overexpression caused no
meaningful change in the global abundance of H3K9ac marks in whole cell extracts (Fig.
9A, insert), there was a considerable loss of H3K9ac marks in repeats.
HLCS overexpression caused a decrease of H3K9ac marks in LTR15, LTR22,
Chr1alpha, and Chr4alpha compared with HLCS-normal controls (Fig. 9B, including a
blown up presentation of the Chr1alpha and Chr4alpha data). The decreases amounted to
the loss of 50%, 68%, 62%, and 50% of H3K9ac marks in LTR15, LTR22, Chr1alpha,
and Chr4alpha, respectively. The abundance of H3K9ac marks did not change in the
GAPDH promoter in euchromatin, consistent with a locus-specific effect of HLCS.
The HLCS-dependent depletion of H3K9ac marks in LTRs caused an 83% decrease in
the global abundance of mRNA coding for LTRs in HEK293 cells (Fig. 9C), using
primers that do not distinguish among the transcriptionally active LTR in the human
genome (Chew et al., 2008). Again, effects of HLCS overexpression on transcriptional
activity were not specific for LTRs, but were also seen in Chr1alpha andChr4alpha
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repeats for which the abundance of transcripts decreased by 81% and 82%, respectively,
compared with HLCS-normal controls.

Discussion
This is the first report suggesting that HLCS interacts physically with N-CoR and
HDAC1, thereby promoting the repression of repeats through removing H3K9ac marks.
This paper supports a model in which HLCS and biotin participate in the repression of
genes at the epigenetic level through orchestrating the assembly of a multi-protein gene
repression complex that integrates DNA methylation, histone H3 methylation, and
histone deacetylation events (Li et al., 2013; Xue et al., 2013). There is high confidence
that the reported interactions are real, based on the following lines of reasoning. First, the
interactions reported in this paper are consistent predictions by a protocol for identifying
HLCS-binding proteins in silico (Li et al., 2013). Second, the in silico predictions were
validated experimentally using three independent procedures, i.e., coimmunoprecipitation assays, limited proteolysis assays, and split luciferase
complementation assays. Third, the interaction between HLCS and the C-terminus in NCoR was abrogated when the HLCS-binding motif was altered by point mutation or
deletion. Fourth, N-CoR C-terminus, HDAC1, and HDAC1Δ31 are targets for
biotinylation by HLCS in vitro. Fifth, the interactions between HLCS and other
chromatin proteins is mediated by the HLCS N-terminus, which is also responsible for
mediating interactions between HLCS and its classical carboxylase substrate (Hassan et
al., 2009a; Ingaramo and Beckett, 2009). Sixth, overexpression of HLCS causes a
substantial, locus-specific loss of H3K9ac marks in LTRs and pericentromeric alpha
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satellite repeats. In addition, this report is consistent with previous studies in healthy
adults, Drosophila melanogaster, and mammalian cell cultures suggesting that the
repression of LTRs and select other loci depends on HLCS and biotin (Camporeale et al.,
2007b; Chew et al., 2008; Gralla et al., 2008; Pestinger et al., 2011; Rios-Avila et al.,
2012).
Based on this report, it is a plausible assumption that loss of HLCS or deficiency of biotin
may cause a de-repression of repeats, which may impair genome stability. For example,
LTRs make up about 8% of the human genome and at least 51 LTRs are transcriptionally
competent (Buzdin et al., 2006). Repetitive elements such as LTRs pose a burden to
genome stability, as their mobilization facilitates recombination between nonhomologous loci, leading to chromosomal deletions and translocations (Kazazian, 2004;
Martens et al., 2005). Mobilization of LTR transposons is associated with 10% of all
spontaneous mutations in mice (Waterston et al., 2002). The transcriptional activity of
LTRs is controlled by histone acetylation and other epigenetic marks; inhibition of
HDACs leads to an increase in LTR transcription (Brunmeir et al., 2010). De-repression
of LTRs may impair genome stability through insertional mutagenesis, recombination
events that cause translocations and other rearrangements, de-regulation of genes in the
host genome mediated by LTR promoter activity, and antisense effects if transcription
extends into exon sequence downstream of the transposon (Yoder et al., 1997).
Our discovery that N-CoR and HDAC1s are targets for biotinylation of HLCS is also of
great interest in the field of protein biotinylation. Previous studies suggest that
biotinylation sites in the histone methyltransferase EHMT-1 are important for
strengthening HLCS/EHMT-1 interactions (Li et al., 2013). The same appears to be the
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case for K2325 in N-CoR which was important for mediating HLCS/N-CoR interactions
in limited proteolysis assays. We are in no position to formally conclude that
biotinylation of K2325 in N-CoR is important for mediating these interactions, because
we do not know the exact biotinylation site(s) in N-CoR. However, it is becoming
increasingly clear that HLCS and its microbial ortholog BirA are fairly promiscuous
enzymes that catalyze the biotinylation of proteins other than their classical substrates,
i.e., the five mammalian biotin-dependent carboxylases (Kobza et al., 2008; Bao et al.,
2011; Li et al., 2013). We have discovered 108 novel biotinylated proteins in human cells
(Li Y et al., submitted), but shall point out that not all lysine-containing peptides and
proteins are substrates for biotinylation by HLCS (Hassan et al., 2009b), suggesting that
some of these biotinylation events have biological importance. For example, we have
recently reported preliminary findings that HLCS biotinylates K10 and K12 in the c-myc
promoter binding protein MBP-1, and that biotinylation of MBP-1 decreases the
expression of c-myc and cyclooxygenase 2 oncogenes (Zhou et al., 2013).
Some uncertainties remain. First, we do not know for certain that biotinylation of N-CoR
and HDAC1s contributes toward strengthening the binding between HLCS and other
proteins. Theoretically, it is possible that point mutations and deletion can have the same
effect without depending on changes in protein biotinylation. Second, the HLCS/HDAC
interaction caused a considerable decrease in the proteolytic degradation of HDAC1s in
limited proteolysis assays, but did not slow the degradation of HLCS. We speculate that
target sites for proteolytic degradation are exposed on the surface of HLCS upon
interaction with HDAC1s. Unfortunately, no 3-D structures are available for human
HLCS, making it difficult to test the validity of our speculation. Third, we do not know
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yet whether HLCS also interacts with HDAC2, which has a high sequence similarity
compared with HDAC1 (Brunmeir et al., 2009).
We conclude that HLCS exerts some of its roles in gene regulation through the formation
of multi-protein gene repression complex in human chromatin. Possible members of this
complex include proteins involved in DNA methylation, EHMT-1, N-CoR, and HDAC1.
This model also suggests that the roles of HLCS in metabolism go far beyond that of a
ligase that attaches biotin to carboxylases. We are currently in the process of creating an
HLCS knockout mouse model that will allow us to shed some additional light on the
roles of HLCS in cell biology and signaling.

Materials and Methods
Prediction of HLCS-binding proteins
In previous studies, we have shown that HLCS-binding proteins in chromatin share the
GGGG(K/R)G(I/M)R motif (Li et al., 2013). A BLAST search was conducted to identify
proteins containing this motif, revealing N-CoR as a candidate for binding to HLCS (see
Results). N-CoR ushers histone deacetylases HDAC1and 2 to N-CoR docking sites,
thereby facilitating histone deacetylation and a repressive chromatin environment (Alland
et al., 1997; Heinzel et al., 1997; Nagy et al., 1997). The amino acid sequences in
HDAC1 and HDAC2 are 83% identical, and the sequences in the catalytic core domain
and the C-terminal tail are nearly identical (Brunmeir et al., 2009). Subsequent
experiments used HDAC1 as a model for deacetylases.
Cell lines and HLCS overexpression

36

Human embryonic kidney HEK293 cells (American Type Culture Collection) were
cultured in Dulbecco's Modified Eagle's Medium (Thermo Scientific) containing 10%
fetal bovine serum, 1% L-glutamine, 1% penicillin/streptomycin and 0.1% sodium
pyruvate. HLCS overexpression cells were created by transfecting HEK293 cells with
plasmid FLAG/Myc-HLCS using electroporation as described previously (Xue et al.,
2013). The expression of HLCS was assessed by western blot analysis and quantitative
real-time PCR (qRT-PCR) as described previously using the PCR primer pair denoted
“25” in Table 1 (Chew et al., 2006).
Plasmids
Full-length human HLCS (GenBank NM_000411) was subcloned from plasmid
pGBKT7-HLCS (Hassan et al., 2009a) into vectors pCMV-Myc and pCMV-HA
(Clontech) using SfiI and SalI, thereby creating plasmids pCMV-Myc-HLCS and pCMVHA-HLCS. Previous studies suggest the existence of four distinct domains in human
HLCS (Hassan et al., 2009a). Myc-tagged overexpression plasmids coding for the
individual domains were created as described previously (Hassan et al., 2009a), using
plasmid pGBKT7-HLCS as template, PCR primer pairs 1, 2, 3, and 4, and vector pCMVMyc as acceptor, thereby creating plasmids pCMV-Myc-HLCS-NT (N-terminus,S2-F446),
pCMV-Myc-HLCS-CD (central domain,F471-S575), pCMV-Myc-HLCS-L (linker
domain,T610-V668), and pCMV-Myc-HLCS-CT (C-terminus,H669-R718), respectively.
Plasmid pET41a-HLCS codes for glutathione S-transferase (GST)-tagged recombinant
HLCS and was prepared as described previously using PCR primer pair 5 (Bao et al.,
2011).
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N-CoR (GenBank NM_006311) is a 270-kDa protein, containing three autonomous
repression domains and a conserved bipartite nuclear receptor interaction domain
(Horlein et al., 1995; Ishizuka and Lazar, 2005). In order to achieve reasonable
transfection efficiencies (through keeping plasmids reasonably small) and to assign
putative interactions with HLCS to distinct domains in N-CoR, the following three
overlapping fragments of N-CoR were cloned using HEK293 cell cDNA as template
(Fig. 2A): N-terminal domain (NT), central domain (CD), and C-terminal domain (CT).
PCR reactions were conducted using primers 6 (NT), 7 (CD), and 8 (CT); PCR products
were digested using EcoRI and KpnI and cloned into vectors pCMV-Myc and pCMVHA, thereby creating plasmids pCMV-Myc-N-CoR-NT, pCMV-Myc-N-CoR-CD,
pCMV-Myc-N-CoR-CT, pCMV-HA-N-CoR-NT, pCMV-HA-N-CoR-CD, and pCMVHA-N-CoR-CT. Lysine (K) to arginine (R) mutations and GGGG(K/R)G(I/M)R motif
deletion were created using pCMV-Myc-N-CoR-CT as template and the GENEART SiteDirected Mutagenesis System (Invitrogen), thereby creating plasmids pCMV-Myc-NCoR-CTK2323R (primer pair 9), pCMV-Myc-N-CoR-CTK2325R (primer pair 10), and
pCMV-Myc-N-CoR-CTdel (primer pair 11). For the preparation of recombinant proteins,
pCMV-Myc-N-CoR-NT, pCMV-Myc-N-CoR-CD, and pCMV-Myc-N-CoR-CT were
PCR amplified using primers 12, 13, and 14, and the three N-CoR domains were
subcloned into the pET41a vector using EcoRI and SacI, thereby creating plasmids
pET41a-N-CoR-NT, pET41a-N-CoR-CD, and pET41a-N-CoR-CT, respectively.
HDAC1 (GenBank NM_004964) and its novel splicing variant HDAC1Δ31, which lacks
the entire 31 amino acids encoded by exon 7 (Liu D and Zempleni J, unpublished), were
cloned from HEK293 cell cDNA into vector pCMV-Myc and pCMV-HA using PCR
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primer pair 15, and EcoRI and KpnI, thereby creating plasmids pCMV-Myc-HDAC1,
pCMV-Myc-HDAC1Δ31, pCMV-HA-HDAC1, and pCMV-HA-HDAC1Δ31. HDAC
reading frames were subcloned into the pET41a vector using PCR primer pair 16, and
EcoRI and SacI to create plasmids pET41a-HDAC1 and pET41a-HDAC1Δ31 for
preparing recombinant HDAC1 and HDAC1Δ31, respectively.
Two fragments of Photinus pyralis firefly luciferase (N-terminus, E2-G416; C-terminus,
M398-C550) were cloned and used to create split luciferase reporter plasmids. The Nterminal fragment was cloned using plasmid pGL3-Control (Promega) as template
(primer pair 17) and inserted into pCMV-Myc, pCMV-Myc-HLCS, and pCMV-MycTP53 using KpnI and NotI, thereby creating plasmids pCMV-Myc-NLuc, pCMV-MycHLCS-NLuc, and pCMV-Myc-TP53-NLuc. The C-terminal fragment was also cloned
using plasmid pGL3-Controlas template (primer pair 18) and inserted into pCMV-Myc,
pCMV-Myc-N-CoR-NT, pCMV-Myc-N-CoR-CD, pCMV-Myc-N-CoR-CT, pCMVMyc-HDAC1, pCMV-Myc-HDAC1Δ31, pCMV-Myc-MDM2, and pCMV-MycCDK3using SfiI and EcoRI, thereby creating plasmids pCMV-Myc-CLuc, pCMV-MycN-CoR-NT-CLuc, pCMV-Myc-N-CoR-CD-CLuc, pCMV-Myc-N-CoR-CT-CLuc,
pCMV-Myc-HDAC1-CLuc, pCMV-Myc-HDAC1Δ31-CLuc, pCMV-Myc-MDM2-CLuc,
and pCMV-Myc-CDK3-CLuc, respectively (Fig. 2B).
The following control plasmids were created for the split luciferase complementation
assay. Human tumor suppressor TP53 (GenBank NM_000546) was cloned from HEK293
cell cDNA into vector pCMV-Myc using primer pair 19 and SfiI and SalI, thereby
creating plasmid pCMV-Myc-TP53. E3 ubiquitin-protein ligase MDM2 (GenBank
NM_002392) and cyclin-dependent kinase 3 (CDK3; Genbank NM_001258) were cloned
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from HEK293 cell cDNA into vector pCMV-Myc using ECoRI and XhoI, thereby
creating plasmid pCMV-Myc-MDM2 (primer pair 20) and pCMV-Myc-CDK3 (primer
pair 21).
Co-immunoprecipitation assays
HEK293 cells were co-transfected with equal amounts of overexpression and control
vectors in permutations as described in Results, using TurboFect reagent (Thermo
Scientific) according to the manufacturer’s instructions (Fermentas). Cells (4 x 106) were
collected 24 h after transfection and lysed in 20 mM Tris HCl buffer (pH 8.0), containing
137 mM NaCl, 10% glycerol, 1% Triton X-100, and 2 mM EDTA, phenylmethylsulfonyl
fluoride, and protease inhibitor cocktail (Sigma-Aldrich). Target proteins were
precipitated with mouse monoclonal anti-Myc (Origene), rabbit polyclonal anti-HA
(Abcam), and 100 µL settled protein A beads (Pierce). Precipitated proteins were boiled
in LDS (lithium dodecyl sulfate) sample buffer (Invitrogen) and analyzed by western blot
with the antibodies named in Results. Non-transfected HEK293 cells were used as
negative controls.
Limited proteolysis assays
This assay is based on the principle that the proteolytic digestion of proteins by dilute
proteases is slowed, if two or more proteins interact physically (Chazin, 2007).
Recombinant proteins were overexpressed in Arctic Express (DE3) competent cells
(Stratagene) and purified using GSTrap HP Columns (GE Healthcare) according to the
manufacturer's instructions. The GST tag was removed using thrombin, and the identity
of recombinant proteins was assessed by western blot analysis. Limited proteolysis assays
were performed using recombinant HLCS and equal amounts of recombinant N-CoR
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fragments, HDAC1, or HDAC1Δ31 in 150 mM Tris acetate buffer (pH 7.5), containing
0.6 mM dithiothreitol and 90 mM MgCl2. After 1 h of pre-incubation at 37°C, aliquots
were collected prior to addition of trypsin (10 ng trypsin/µg recombinant protein; SigmaAldrich), and equal volumes of aliquots were collected at timed intervals after initiation
of digestion. Digestion of proteins was visualized by gel electrophoresis and staining with
coomassie blue.
Split luciferase complementation assay
This assay is based on the principle that luciferase produces chemiluminescence only if
its N- and C-termini are in close physical proximity (Luker and Piwnica-Worms, 2004).
If the N- and C-terminal fragments of luciferase are fused to proteins, chemiluminescence
will be produced only if the two fusion proteins interact physically, thereby bringing the
luciferase termini in close physical proximity. HEK293 cells were co-transfected with
equal amounts of luciferase fusion constructs using TurboFect reagent. Cells were
collected 48 h after transfection and cell suspension was mixed with an equal volume of
LucLite substrate (Promega). Luminescence was quantified using a microplate
scintillation and luminescence counter (Packard) and normalized by β-gal activity as
described previously (Griffin et al., 2003). Fusion constructs of TP53and MDM2 were
used as positive controls (ElSawy et al., 2013); fusion construct of TP53and CDK3 were
used as negative controls (Tsuji et al., 2002).
Biotinylation of HLCS-binding proteins by recombinant HLCS
There is precedent for the HLCS-dependent covalent binding of biotin to chromatin
proteins such as EHMT-1 and histones (Bao et al., 2011; Li et al., 2013). We determined
whether putative HLCS-interacting proteins are potential targets for biotinylation by
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HLCS. Briefly, recombinant N-CoR fragments, HDAC1, and HDAC1Δ31were incubated
with recombinant HLCS in biotinylation buffer and protein-bound biotin was probed with
anti-biotin (Abcam) as described previously (Hassan et al., 2009b). Equal loading of gels
was confirmed using coomassie blue.
Micro chromatin immunoprecipitation (μChIP) assay
The enrichment of histone H3 K9-acetylation (H3K9ac) marks in long terminal repeats
(LTRs) 15 and 22 and pericentromeric alpha satellite repeats in chromosomes 1
(Chr1alpha) and 4 (Chr4alpha) in HLCS overexpressed cells was assessed by μChIP as
described (Dahl and Collas, 2008; Pestinger et al., 2011). ChIP grade anti-H3K9ac and
anti-H3 (Abcam) were used to precipitate chromatin associated with H3K9ac marks and
to normalize for nucleosomal occupancy, respectively. The promoter regulating the
expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) localizes in
euchromatin and was used as control locus. Data are expressed as percentage of input
DNA.
qRT-PCR
The abundance of mRNA coding for LTRs 15 and 22 and Chr1alpha and Chr4alpha was
quantified by qRT-PCR using Power SYBR Green PCR Master Mix (Applied
Biosystems). PerfeCTa SYBR Green FastMix (Quanta Biosciences) was used to quantify
the abundance of amplicons in immunoprecipitated chromatin (Pestinger et al., 2011).
PCR primer pairs are listed in Supplementary Online Table S1 (Buzdin et al., 2006;
Kovalskaya et al., 2006).
Statistics
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Data were tested for normality of distribution by Komolgorov-Smirnov normality test.
Data from split luciferase complementation assays were tested for homogeneity of
variances by Bartlett's test and analyzed for significance of difference by one-way
ANOVA. Data from μChIP and qRT-PCR were tested for homogeneity of variances by
F-test and analyzed by student’s t-test (SAS, 2008). Variances of data from qRT-PCR
testing HLCS expression levels were heterogeneous and therefore the conservative
Mann-Whitney U test was used for analysis. All analyses and data points are based on
three biologically independent repeats. StatView 5.0.1 (SAS Institute) was used to
perform all calculations. Differences were considered significant if p<0.05. Data are
expressed as means ± S.D.
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Table 1.1 PCR primers.
P1

Target;2
template

1

HLCS-NT
cDNA

2

Primer Sequences 5’→ 3’

F/R

GCCGAATTCCCATGGAAGATAGACTCC

F

CAGGTCGACCCGAAGGCCTCCATGTTG

R

HLCS-CD
cDNA

GCCGAATTCCCTTTGCCGAAGTGACCC

F

CAGGTCGACCCGTCACTGTAATAAATA

R

3

HLCS-L
cDNA

GCCGAATTCCCACCATCTGCATCAACG

F

CAGGTCGACCCGTGGACCCAGTATCGG

R

4

HLCS-CT
cDNA

GCCGAATTCACAGTGGTCAGCAAGTCC

F

CAGGTCGACTCTCAGCATGTCGAAGGA

R

5

HLCS
cDNA

GTCCGAATTCGGGGAGCATGTTGGCAGAG

F

ATTTCTCGAGCCCGCCGTTTGGGGAG

R

6

N-CoR-NT
cDNA

GCGGAATTCCCTCAAGTTCAGGTTATCCT

F

GCGGGTACCATCCAAGTCTCTTTCTTTGG

R

7

N-CoR-CD
cDNA

GCGGAATTCCCACCAAAGCTGACTCTGT

F

GCGGGTACCAGCACTTGCAGCAGCTGC

R

8

N-CoR-CT
cDNA

GCGGAATTCCCCCTGGTACACAGATTACTTT

F

GCGGGTACCGTCATCACTATCCGACAGG

R

9

CTK2323R
cDNA

TCAGGAGGAGTTTGCAGACCAAAGCTGATCAGC

F

TTTGGTCTGCAAACTCCTCCTGAATGAGGTGAT

R

10

CTK2325R
cDNA

GGAGTTTGCAAACCAAGGCTGATCAGCAAGTCA

F

ATCAGCCTTGGTTTGCAAACTCCTCCTGAATGA

R

11

CTdel
cDNA

CCATCACCTCATTCAAGCAAGTCAAACAGC

F

TGCTTGAATGAGGTGATGGGTCCCCTTCCT

R

12

N-CoR-NT
cDNA

GCGGAATTCTCAAGTTCAGGTTATCCTCC

F

GCGGAGCTCATCCAAGTCTCTTTCTTTGG

R

13

N-CoR-CD
cDNA

GCGGAATTCACCAAAGCTGACTCTGTGG

F

GCGGAGCTCAGCACTTGCAGCAGCTGC

R

14

N-CoR-CT
cDNA

GCGGAATTCCCTGGTACACAGATTACTTTCC

F

GCGGAGCTCGTCATCACTATCCGACAGG

R

GCGGAATTCAAGCGCAGACGCAGGG

F

15 HDAC1/Δ31
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cDNA

GCGGGTACCGGCCAACTTGACCTCCTCCTTG

R

16

HDAC1/Δ31
cDNA

GCGGAATTCAAGCGCAGACGCAGGG

F

GCGGAGCTCGGCCAACTTGACCTCCTCCTTG

R

17

NLuc
cDNA

CCCGTCGACCGAAGACGCCAAAAAC

F

CCCGCGGCCGCTCCATCCTTGTCAAT

R

18

CLuc
cDNA

GCGGGCCATGGAGGCCATGTCCGGT

F

GCGGAATTCGCACGGCGATCTTTCCG

R

19

TP53
cDNA

CGGCCATGGAGGCCGAGGAGCCGCAGTCA

F

GCGGTCGACCGTCTGAGTCAGGCCCTTCTGTC

R

20

MDM2
cDNA

GCGGAATTCCCGTGAGGAGCAG

F

GCGCTCGAGAGGGGAAATAAGTTAGCA

R

21

CDK3
cDNA

GCGGAATTCCCGATATGTTCCAGAA

F

GCGCTCGAGAATGGCGGAATCGCT

R

22

LTR15
gDNA

TTGTCATTGGTTCTGTGTAGGG

F

CCTCCATATGCTGAACGCTG

R

23

LTR22
gDNA

ATGGATTCAGCCTGTGTCTTTGGG

F

CCTCCATATGCTGAACGCTG

R

24

GAPDH
gDNA

ATGACAAGCATGAGGCAGAG

F

CAACCAGGACCGTTAACCCTTTCT

R

25

HLCS
cDNA

ATGGAAGATAGACTCCACAT

F

TGAGACCTGATCCTTAACTTCC

R

26

U5
cDNA

AACTCAGAGGCTGGCG

F

AGACACAGAGACAAAGTATAGAGA

R

27

R-U5
cDNA

GCGGGCAGCAATACTGCTTTGTAA

F

ACCAGCGTTCAGCATATGGAGGAT

R

28

GAPDH
cDNA

TCCACTGGCGTCTTCACC

F

GGCAGAGATGATGACCCTTT

R

29

Chr1alpha
cDNA, gDNA

CATCGAATGGAAATGAAAGGAGTC

F

ACCATTGGATGATTGCAGTCAA

R

30

Chr4alpha
cDNA, gDNA

CTGCACTACCTGAAGAGGAC

F

1

GATGGTTCAACACTCTTACA
R
Abbreviations: cDNA, complementary DNA; F, forward; gDNA, genomic DNA;
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P, primer pair; R, reverse; R-U5 = region between R and U5 of LTR of HERV-K
families; U5 = U5 region of LTR of HERV-K families.
2

Genbank entries: Chr1alpha = chromosome 1 alpha satellite repeats (M26919);

Chr4alpha = chromosome 4 alpha satellite repeats (M38467); CDK3 = cyclin-dependent
kinase 3 (NM_001261); GAPDH = glyceraldehyde-3-phosphate dehydrogenase
(NG_007073 for genomic DNA, NM_002046 for complementary DNA); HDAC1 =
histone deacetylase 1 (NM_004964); HLCS = holocarboxylase Synthetase
(NM_000411); LTR15 = intact LTR (AC116309); LTR22 = solitary LTR (AL451165);
MDM2 = E3 ubiquitin-protein ligase MDM2 (NM_002392); N-CoR = nuclear receptor
corepressor (NM_006311); TP53 = tumor protein p53 (NM_000546).
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Figures and legends

Figure 1.1 HLCS-containing multi-protein gene repression complex. The binding of
HLCS to chromatin depends on physical interactions of HLCS with the maintenance
DNA methyltransferase DNMT1 and the methyl CpG binding protein 2, MeCP2.
Chromatin-bound HLCS recruits the eukaryotic histone H3 methyltransferase EHMT-1,
nuclear receptor corepressor N-CoR, and histone deacetylases HDACs.
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Figure 1.2 Schematics of domains in N-CoR and luciferase constructs used in the split
luciferase complementation assays. (A) The N-terminus of N-CoR contains
transcriptional repression domains (RDs) responsible for the recruitment of additional
components of the corepressor complex such as HDACs, mSin3, and GPS2. A pair of
potent repressor motifs known as SANT motifs (SWI3, ADA2, N-CoR, and TFIIIB) is
positioned between the RDs; SANT motifs recruit HDAC3 and histones to the repressor
complex in order to enhance HDAC3 activity. The C-terminus of N-CoR includes a
nuclear receptor interaction domain (NID), which binds ligand-free nuclear receptors. In
order to assign putative interactions with HLCS to distinct domains in N-CoR, three
overlapping fragments of N-CoR were cloned, N-terminal domain (NT), central domain
(CD), and C-terminal domain (CT). (B) In split luciferase complementation assays, Nterminal and C-terminal fragments are fused to interacting proteins. Physical interactions
between the two proteins reconstitute luciferase activity.
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Figure 1.3 HLCS
H
interracts physically with N
N-CoR. (A) In
I co-immuunoprecipitaation
assays, Myc-HLCS annd HA-N-CooR-CT weree overexpreessed in HEK
K293 cells and cell
lysates werre precipitatted with anti-Myc or annti-HA. Protteins were rresolved by
electrophorresis and proobed with anti-HA
a
or aanti-HLCS. Empty vectors in vario
ous
permutationns and non--transfected cells were used as neggative controols. (B) As described
for A, but tags
t
were sw
wapped. (C)) HA-taggedd HLCS andd Myc-taggged wild-typpe or
mutant N-C
CoR C-term
minus were overexpress
o
ed in HEK2293 cells annd cell lysatees were
precipitatedd with anti-M
Myc or antii-HA. Proteins were ressolved by electrophoreesis and
probed withh anti-HLCS or anti-M
Myc. Non-traansfected ceells were useed as negatiive
controls. (D
D) Limited proteolysis
p
assays: recoombinant HLCS
H
and N
N-CoR C-terrminus
were pre-inncubated priior to trypsiin digestion (lower gel)). Negative controls weere
generated by
b omissionn of HLCS or
o N-CoR C
C-terminus (upper
(
and m
middle gels).
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Figure 1.4 Split luciferase complementation assays for detection of HLCS and N-CoR
interaction in HEK293 cells. Fusion constructs of TP53 and MDM2 were used as positive
controls, and TP53 and CDK3 were used as negative controls. Values are the mean ± S.D.
of independent experiments (n=3; *p-value<.01 vs. background control for selfassociation and negative control).
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Figure 1.5 HLCS
H
interracts physically with H
HDAC1s. (A
A) In co-imm
munoprecipiitation
assays, Myc-HLCS annd HA-HDA
AC1s were ooverexpresssed in HEK2293 cells annd cell
lysates werre precipitatted with anti-Myc or annti-HA. Protteins were rresolved by
electrophorresis and proobed with anti-HDAC1
a
1 or anti-HL
LCS. Emptyy vectors in various
permutationns and non--transfected cells were used as neggative controols. (B) As described
for A, but tags
t
were sw
wapped. (C)) Limited prroteolysis asssays: recom
mbinant HL
LCS and
HDAC1s were
w pre-inccubated prioor to trypsinn digestion (middle
(
andd right panells).
Negative coontrols weree generatedd by omissioon of HLCS or HDAC11s (left paneel).
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Figure 1.6 Split luciferase complementation assays for detection of HLCS and HDAC1s
interaction in HEK293 cells. Fusion constructs of TP53 and MDM2 were used as positive
controls, and TP53 and CDK3 were used as negative controls. Values are the mean ± S.D.
of independent experiments (n=3; *p-value<.01 vs. background control for selfassociation and negative control).
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Figure 1.7 The
T roles off HLCS dom
mains in meediating inteeractions wiith N-CoR and
a
HDAC1s. M
Myc-taggedd HLCS andd HA-taggedd N-CoR C--terminus (A
A) or HDAC
C1s (B)
were overexxpressed in
n HEK293 cells.
c
Cell lyysates were precipitatedd with anti-M
Myc and
probed withh anti-HA. Non-transfe
N
ected cells were
w used as negative ccontrols.
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Figure 1.8 N-CoR
N
and
d HDAC1s are
a targets for
f biotinylaation of HLC
CS. (A) Reccombinant
N-terminuss, central doomain, and C-terminus
C
in N-CoR were
w incubaated with reccombinant
HLCS, biottin, and cofa
factors for biotinylationn for up to 2 h. N-CoR--bound biotiin was
detected wiith anti-biottin. Negativve controls were
w createdd by omittinng N-CoR fragments
fr
or HLCS. Equal
E
loadinng was conffirmed by cooomassie bllue stain. (B
B) Similarlyy,
biotinylatioon of recom
mbinant HDA
AC1s by HL
LCS was coonducted.
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Figure 1.9 Transcriptio
T
onal represssion of repeats by HLC
CS overexprression. (A)
Transfectioon with plasmid p3XFL
LAG-Myc-C
CMV-26-HL
LCS producced a stable
overexpresssion of HLC
CS in HEK2293 cells, juudged by qR
RT-PCR (n=
=3; *p-value<.05 vs.
untransfectted controls)) and western blot anallysis. GAPD
DH and histtone H3, loaading
controls. (B
B) The enricchment of H3K9ac
H
marrks in loci coding
c
for L
LTR15, LTR
R22,
Chr1alpha, Chr4alpha,, and GAPD
DH in HLCS
S overexpreession HEK
K293 cells an
nd controls
(n=3; **p-vvalue<.00011 vs. FLAG
G/Myc-HLCS controls).. The insert depicts a blown-up
version of tthe Chr1alppha and Chr44alpha dataa. (C) The abbundance of transcriptss coding forr
LTRs, Chr11alpha, and Chr4alpha in HLCS overexpressiion HEK2933 cells and controls.
c
Values are the mean ± S.D. of inddependent experiments (n=3; **p-vvalue<.0001 vs.
FLAG/Mycc-HLCS conntrols).
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Abstract
Lysine specific demethylase 1 (LSD1) is a flavin adenine dinucleotide (FAD)-dependent
demethylase that catalyzes the removal of methyl groups from lysine-4 in histone H3
(H3K4me1, H3K4me2), thereby mediating gene repression. Here we tested the
hypothesis that riboflavin deficiency causes a loss of LSD1 activity in human
hepatocarcinoma HepG2 cells, leading to an accumulation of H3K4me2 marks in the
albumin promoter and aberrant up-regulation of albumin expression. Cells were cultured
in riboflavin-defined media providing riboflavin at levels representing moderately
deficient (3.1 nmol/L), sufficient (12.6 nmol/L), and supplemented (301 nmol/L) in
humans for 7 days. Efficacy of treatment was confirmed by assessing glutathione
reductase activity and levels of reduced glutathione as markers of riboflavin status. LSD
activity was 21% greater in riboflavin-supplemented cells compared with riboflavindeficient and sufficient cells. Loss of LSD activity was associated with a gain in the
abundance of H3K4me2 marks in the albumin promoter; the abundance of H3K4me2
marks was about 170% higher in riboflavin-deficient cells compared with sufficient and
supplemented cells. The abundance of the repression mark, K9-trimethylated histone H3
(H3K9me3) was 38% lower in the albumin promoter of riboflavin-deficient cells
compared with the other treatment groups. The expression of albumin mRNA was
aberrantly increased by 200% in riboflavin-deficient cells compared with sufficient and
supplemented cells. In conclusion, riboflavin deficiency impairs gene regulation by
epigenetic mechanisms, mediated by a loss of LSD1 activity.

Key Words: albumin, LSD1, H3K4me2, demethylation, riboflavin

65

Introduction
Riboflavin is an essential precursor in the synthesis of the flavocoenzymes, FMN, and
FAD (Pinto and Rivlin, 2013). FMN and FAD, and their reduced forms FMNH2 and
FADH2, serve as coenzymes in a large number of redox reactions and also a
comparatively small number of reactions with no net redox change in mammalian
intermediary metabolism (Bornemann, 2002; Henriques et al., 2010; Pinto and Rivlin,
2013). Representative examples of flavin-dependent pathways include reactions in
electron transport chain, citric cycle, fatty acid β-oxidation, glutathione homeostasis, and
protein folding. In most cases, flavocoenzymes are not covalently attached to apoproteins
but form noncovalent complexes (Janin and Chothia, 1978). Flavin metabolites other than
riboflavin, FMN, and FAD have been identified in human plasma and urine by
McCormick and co-workers (Chastain and McCormick, 1987a; Chastain and
McCormick, 1987b; Chastain and McCormick, 1988; Zempleni et al., 1996a), but these
metabolites probably lack biological activity.
Rather recently, a new FAD-dependent enzyme has been identified: the nuclear amine
oxidase homolog, lysine specific demethylase 1 (LSD1) (Shi et al., 2004; Culhane and
Cole, 2007). LSD1 demethylates lysine-4 in monomethylated (H3K4me1) and
dimethylated (H3K4me2) histone H3, thereby removing gene activation marks and
mediating gene repression (Forneris et al., 2005; Kouzarides and Berger, 2007).
H3K4me1 and H3K4me2 are enriched in chromatin adjacent to transcription start sites of
active genes, whereas inactive gene promoters are characterized by low levels of H3K4
methylation marks (Barski et al., 2007). Consistent with its role as a transcriptional
repressor, LSD1 forms a complex with the REST corepressor and histone deacetylases 1
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and 2, which synergize with LSD1 in gene repression by mediating the deacetylation of
histone tails (Humphrey et al., 2001; You et al., 2001; Hakimi et al., 2002).
Loss of LSD1 precipitates strong phenotypes. For example, LSD1 knockout is embryonic
lethal in mice (Wang et al., 2007). LSD1-deficient mouse embryonic stem cells are
characterized by defects in differentiation, severe growth impairments due to increased
cell death and impaired cell cycle progression, and global DNA hypomethylation (Wang
et al., 2009).
To date, there is no published report regarding the impact of riboflavin nutrition on LSD1
activity. This knowledge gap has possible implications for disease prevention, because a
variety of factors can cause riboflavin depletion, including alcohol consumption (Pinto et
al., 1987; Horvath, 2012), genetic defects of riboflavin transporter genes (Pinto et al.,
1987; Horvath, 2012), impaired conversion of riboflavin to its coenzyme forms in
persons with thyroid hormone insufficiency (Cimino et al., 1987), and abnormal
riboflavin metabolism such as inhibition of the incorporation of riboflavin into FAD in
response to treatment with tricyclic and tetracyclic compounds such as chlorpromazine,
tetracycline, and adriamycin (Pinto et al., 1981; Dutta et al., 1988). Note that current
recommendations for riboflavin intake are largely based on studies using the FADdependent glutathione reductase as marker of riboflavin nutrition, without considering the
potentially more subtle FAD-dependent changes in the epigenome (Beutler, 1969a;
Beutler, 1969b; National, 1998).
Human hepatocarcinoma HepG2 cells were chosen as model in this study because flavindependent pathways in these cells respond robustly to changes in riboflavin
concentrations in culture media, when testing levels that represent moderate deficiency,
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sufficiency, and supplementation in adults (Manthey et al., 2005; Werner et al., 2005;
Manthey et al., 2006). The albumin gene was chosen as a target locus because HepG2
cells produce albumin in large quantities and albumin plays crucial roles in serum
osmolarity and transport of vitamins, fatty acids, and hormones (Bernardi et al., 2012).
Using this model system, we tested the hypothesis that riboflavin deficiency causes a loss
of LSD1 activity, leading to an enrichment of H3K4me2 marks in the albumin gene locus
and an aberrantly high expression of albumin gene.

Results
Treatment efficacy
HepG2 cells showed the expected response to alterations in riboflavin concentrations in
culture media, i.e., glutathione reductase activity was higher in riboflavin-supplemented
cells compared with deficient and sufficient cells, and the levels of reduced glutathione
were lower in riboflavin-deficient cells compared with sufficient and supplemented cells
(Fig. 1A and B). These findings are consistent with efficacy of riboflavin treatment in
HepG2 cell cultures in previous studies (Manthey et al., 2005; Manthey et al., 2006).
LSD activity and expression
LSD activity depended on the concentration of riboflavin in cell culture media. When
HepG2 cells were cultured in riboflavin-defined medium for 7 days, LSD activity was 21%
greater in riboflavin-supplemented cells compared with deficient and sufficient cells (Fig.
1C).
The expression of LSD1 mRNA was about 30% higher in riboflavin-deficient cells than
sufficient and supplemented cells (Fig. 1D). LSD1 protein abundance followed a similar
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pattern (arbitrary units of gel densitometry): 9.44 ± 0.87 for deficient cells vs. 6.81 ± 0.87
for sufficient cells vs. 3.93 ± 0.94 for supplemented cells (p<0.05 for all possible
comparisons).
Transcriptional regulation of the albumin gene
Riboflavin deficiency caused an aberrant expression of albumin in HepG2 cells. The
binding of LSD1 to the albumin promoter was about 90% greater in riboflavin-deficient
cells compared with sufficient and supplemented cells after 7 days of culture (Fig. 1E).
Despite the increase in LSD1 binding, the abundance of H3K4me2 and H3K9me3 marks
was 170% higher and 38% lower, respectively, in the albumin promoter in riboflavindeficient cells compared with sufficient and supplemented cells (Fig. 1F and G). (See
Discussion for a role of LSD1 in the regulation of H3K9me3 repression marks.) These
changes in epigenetic activation and repression marks were associated with albumin
mRNA levels 200% higher in riboflavin-deficient cells compared with sufficient and
supplemented cells (Fig. 1H).

Discussion
While it was recognized nine years ago that LSD1 is a FAD-dependent enzyme (Shi et
al., 2004), this is to our best knowledge the first study to demonstrate the importance of
riboflavin nutrition in the regulation of the H3K4me-dependent gene expression. Our
studies provide unambiguous evidence that LSD1 expression and chromatin binding is
higher in riboflavin-deficient liver cells compared with sufficient and supplemented cells.
This up-regulation was not sufficient to compensate for the depletion of the
flavocoenzyme FAD and holo-LSD1 in riboflavin-deficient cells. Our studies suggest
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that loss of LSD1 activity causes aberrant gene regulation in riboflavin-deficient cells, as
assessed by the accumulation of H3K4me2 gene activation marks in the albumin
promoter and increased albumin gene expression in riboflavin-deficient cells.
We also discovered that the loss of catalytically active LSD1 was associated with a 38%
decrease of H3K9me3 repression marks in the albumin promoter. This observation can be
ascribed to the observed up-regulation of LSD1 expression and promoter binding in
riboflavin-deficient cells, along the following lines of reasoning. Unambiguous evidence
suggests that LSD1 recruits Jumonji C domain-containing protein JMJD2C to gene
promoters; JMJD2C has trimethyl lysine demethylase activity, does not depend on FAD
as coenzyme, and may catalyze the demethylation of H3K9me3 (Wissmann et al., 2007).
We propose that high levels of apo-LSD1 to the albumin promoter causes local
accumulation of JMJD2C, which then leads to the erasure of H3K9me3 marks.
Collectively, the gain of the gene activation mark H3K4me2 and the loss of the gene
repression mark H3K9me3 synergize in the transcriptional activation of the albumin gene
in riboflavin-deficient cells.
Note that albumin gene was chosen as a model, because it is expressed in large quantities
by liver cells, is responsible for about 75% of plasma osmolarity, and hyperalbuminemia
may lead to congestive heart failure and hypertension (Quinlan et al., 2005). Moreover,
previous DNA microarray studies are consistent with aberrant gene regulation in
riboflavin-deficient HepG2 cells (Manthey et al., 2006).
The effects of riboflavin described in this study represent levels of riboflavin in the
plasma of normal adults, spanning the range of moderately deficient pregnant women to
users of over-the-counter riboflavin supplements (Zempleni et al., 1995; Zempleni et al.,
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1996b). It was not necessary to utilize physiologically irrelevant treatments such as zero
riboflavin to elicit meaningful effects on LSD activity and gene regulation. We
acknowledge the possibility that cells other than liver cells might be less susceptible to
loss of flavin-dependent enzyme activities compared with liver cells. For example,
previous studies suggest that HepG2 cells are more susceptible than human lymphoid
Jurkat cells, when using FAD-dependent protein folding as marker (Sauberlich et al.,
1972; Manthey et al., 2005).
We propose that this study depicts the effects of riboflavin depletion on gene regulation
by LSD1, rather than LSD2, based on the following rationale. Although both LSD1 and
LSD2 may catalyze demethylation of H3K4me1/2 through an FAD-dependent reaction
(Karytinos et al., 2009), previous studies suggest that LSD2 may repress genes through a
mechanism independent of its demethylase activity (Yang et al., 2010), suggesting partial
functionality of LSD2 in states of riboflavin deficiency. LSD2 binds to coding regions, as
opposed to promoters, where it synergizes with euchromatic histone methyltransferases
EHMT1/2 and NSD3 in the regulation of transcriptional elongation (Fang et al., 2010).
A few uncertainties remain and warrant further investigation. First, we did not formally
assess whether apo- and holo-LSD1 bind to the albumin promoter with similar affinity.
Such studies will be feasible only when antibodies become available that distinguish
between apo- and the holo-LSD1. Second, histone demethylases other than LSD1 do not
depend on FAD as coenzyme and might rescue FAD-deficient cells regarding H3K4me2
demethylation events. Examples include the H3K4me2 demethylases JARID1A,
JARID1B, JARID1C, and JARID1D, which belong to Jumonji AT-rich interactive
domain subfamily of Jumonji C domain containing proteins (Christensen et al., 2007;
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Iwase et al., 2007; Klose et al., 2007; Lee et al., 2007; Tahiliani et al., 2007; Yamane et
al., 2007).
Even though uncertainties remain, this study provides unambiguous evidence for a role of
riboflavin nutrition in gene regulation by epigenetic mechanisms. Future studies will need
to assess the extent by which moderate riboflavin deficiency causes aberrant gene
regulation and disease in humans.

Materials and Methods
Cell cultures
HepG2 human hepatocarcinoma cells (ATCC, Manassas, VA, passage number 5) were
cultured in riboflavin-defined RPMI-1640 medium (HyClone, Logan, UT) as described
previously (Camporeale and Zempleni, 2003; Manthey et al., 2006). Riboflavin
concentrations in the culture medium were adjusted to 3.1 nmol/L (denoted deficient,
“DEF”), 12.6 nmol/L (denoted sufficient, “SUF”), and 301 nmol/L (denoted
supplemented, “SUP”), taking into account the residual concentrations of riboflavin,
FMN, and FAD in dialyzed fetal bovine serum. Cells were cultured in riboflavinsufficient medium for 7 days before transfer into the riboflavin-defined medium and
continued culture for 7 days before analysis. This protocol was chosen based on previous
studies suggesting that HepG2 cells achieve new steady state levels of flavins within four
days of culture in riboflavin-defined media and that cell proliferation was adversely
impacted after 10 days of culture in riboflavin-deficient media (Manthey et al., 2005;
Werner et al., 2005). Cells cultured in riboflavin-sufficient medium were designated as
the control group.
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Glutathione metabolism
Glutathione reductase is an FAD-dependent enzyme and both the activity of glutathione
reductase and the level of reduced glutathione are robust markers of riboflavin status
(Camporeale and Zempleni, 2003; Manthey et al., 2006). After 7 days in riboflavindefined media, HepG2 cells were harvested and lysed for assessment of glutathione
metabolism. Glutathione reductase activity was quantified in cell lysates containing 0.5
mg protein as described previously (Sauberlich et al., 1972). One unit of glutathione
reductase activity is defined as the change of absorbance at 340 nm per 0.5 mg protein in
10 min of incubation. The concentration of reduced glutathione in lysates was determined
colorimetrically using the 5,5-dithiobis(2-nitrobenzoic acid) reduction assay at 412 nm as
described previously (Tietze, 1969).
LSD activity
LSD activity was measured using the demethylase (LSD-type) activity assay kit (Cayman
Chemical, Ann Arbor, MI) according to the manufacturer’s instructions. One unit of LSD
activity is defined as the ratio of sample fluorescence to background fluorescence. This
assay does not distinguish between the two LSD in the human proteome, LSD1 and
LSD2 (Fang et al., 2010).
Western blot analysis
LSD1 expression was quantified by western blot as described previously (Manthey et al.,
2006), using rabbit polyclonal anti-human LSD1 (Abcam, Cambridge, MA). GAPDH
was probed using anti-GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA) and used as
loading control. Data were quantified by gel densitometry analysis.
Chromatin immunoprecipitation (ChIP) assay
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The enrichment of LSD1, H3K4me2, and K9-trimethylated histone H3 (H3K9me3) in
the promoter region of the human albumin gene (-166 to +58) was assessed by ChIP
assay as described previously (Dahl and Collas, 2008). Immunoprecipitations were
performed with specific antibodies to LSD1, H3K4me2 (Abcam), H3K9me3 (Abcam),
H3 (Abcam), and rabbit IgG (Santa Cruz Biotechnology). Nuclear chromatin extracts
without immunoprecipitation were used as input control. Precipitation of chromatin with
non-specific rabbit IgG was used as negative control. Histone H3 occupancy was used to
normalize H3K4me2 and H3K9me3 occupancy in the albumin promoter.
qRT-PCR
The abundance of mRNA coding for LSD1 and albumin was quantified by qRT-PCR
using Power SYBR Green PCR Master Mix (Applied Biosystems, Carlsbad, CA) as
described previously (Gralla et al., 2008) (Table 1). The relative amount of each gene
was normalized using housekeeping gene GAPDH.
Amplicons from ChIP assays were analyzed using the PerfeCTa SYBR Green FastMix
(Quanta Biosciences, Gaithersburg, MD) as described previously (Pestinger et al., 2011).
The relative occupancy of histones in the albumin promoter were calculated as described
(Wei et al., 2006) and values are reported as the percent of input DNA.
Statistical analysis
Data were distributed normally and variances were homogenous, as assessed by
Komolgorov-Smirnov normality test and Bartlett's test, respectively. Statistical
significance was assessed by one-way ANOVA and Fisher’s protected least significant
difference posthoc test (Institute, 1998). All analyses and data points are based on three
biologically independent repeats. StatView 5.0.1 (SAS Institute, Cary, NC) was used to
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perform all calculations. Differences were considered significant if p-value < 0.05. Data
are expressed as means ± S.D.
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Table 1.1 Oligonucleotide primers used for qRT-PCR
Gene1
ALB
ALB
GAPDH
GAPDH
LSD1

Sequence

F/R2

5’-CTTGAATGTGCTGATGACAGG-3’

F

5’-GCAAGTCAGCAGGCATCTCAT-3’

R

5’-TACATTGACAAGGTCTTGTGGAG-3’

F

5’-TGGGGTTGACAGAAGAGAAAAGC-3’

R

5’-TCCACTGGCGTCTTCACC-3’

F

5’-GGCAGAGATGATGACCCTTT-3’

R

5’-ATGACAAGCATGAGGCAGAG-3’

F

5’-CAACCAGGACCGTTAACCCTTTCT-3’

R

5’-ACCACAACAGACCCAGAAGG-3’

F

Template
cDNA
gDNA
cDNA
gDNA

cDNA
5’-GGTGCTTCTAATTGTTGGAGAG-3’
R
1
Genbank entries: ALB = Homo sapiens albumin (NM_000477.5); GAPDH = Homo

sapiens glyceraldehyde-3-phosphate dehydrogenase (NM_002046.4 for complementary
DNA, NG_007073.2 for genomic DNA); LSD1 = Homo sapiens lysine (K)-specific
demethylase 1 (NM_001009999.2).
2

Abbreviations: cDNA, complementary DNA (for gene expression analysis); F, forward;

gDNA, genomic DNA (for ChIP assays); R, reverse.
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Figures and legends

Figure 1.1 Effects of riboflavin concentrations in culture media on LSD1-dependent gene
regulation in HepG2 cells. (A) Glutathione reductase activity; (B) reduced glutathione; (C)
LSD activity; (D) expression of LSD1 mRNA and protein (insert); (E, F, G) enrichment
of LSD1, H3K4me2, and H3K9me3, respectively, in the albumin promoter; and (H)
albumin mRNA abundance. Values are means ± SD, n=3. a,bMeans not sharing a
common letter are significantly different for the same variable, p-value < 0.05. DEF,
deficient; SUF, sufficient; SUP, supplemented.
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Abstract
Mono- and dimethylation of lysine (K)-4 in histone H3 (H3K4me1, H3K4me2) creates
epigenetic gene activation marks that are enriched near the transcription start site (TSS)
of genes. Lysine specific demethylase 1 (LSD1) is a flavin adenine dinucleotide (FAD)dependent demethylase that catalyzes the demethylation of H3K4me1 and H3K4me2,
thereby mediating gene repression. This study tested the hypothesis that LSD1 activity
depends on the concentrations of the FAD precursor, riboflavin, in cell culture media, and
that riboflavin deficiency causes de-repression of pro-inflammatory cytokines. Human T
lymphoma Jurkat cells were cultured in riboflavin-defined media, representing plasma
levels of riboflavin in moderately deficient, sufficient, and supplemented humans. The
expression of LSD1 mRNA and protein followed the pattern riboflavin-deficient >
riboflavin-sufficient > riboflavin-supplemented cells. However, the increase in LSD1
expression was insufficient to compensate for FAD depletion, and LSD activities were
more than 30% higher in riboflavin-supplemented cells compared with the other
treatment groups. The enrichment of H3K4me2 marks was 11-137% greater in
riboflavin-deficient cells compared with sufficient cells in exon 1 of genes coding for the
pro-inflammatory cytokines interleukin (IL)-1α, IL-1β, IL-6, and tumor necrosis factor-α
(TNF-α). Consistent with the enrichment of gene activation marks, the expression of
mRNA coding for pro-inflammatory cytokines was 62-487% higher in riboflavindeficient cells compared with sufficient cells. These findings support the hypothesis that
riboflavin deficiency contributes toward a pro-inflammatory gene expression pattern
through a loss of LSD1 activity.
Key Words: demethylation, FAD, H3K4me2, pro-inflammatory cytokines, TSS
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Introduction
Epigenetic marks play key roles in the regulation of gene expression. Post-translational
methylation of histones is one such epigenetic event that contributes to gene regulation
(Greer and Shi, 2012). Remarkable progress has been made in characterizing the
distribution of histone methylation marks and assessing the roles these marks in gene
regulation on a genome-wide scale in yeast and several mammalian cell lines (Bernstein
et al., 2002; Barski et al., 2007; Koch et al., 2007; Lee and Mahadevan, 2009; Nair et al.,
2012). These studies implicate methylation of lysine (K)-4 in histone H3 in gene
activation, whereas methylation of K-9 in histone H3 is implicated in gene repression.
Within actively transcribed genes, some methylation marks, e.g., K4-monomethylated
histone H3 (H3K4me1), K4-dimethylated histone H3 (H3K4me2), and K4-trimethylated
histone H3 (H3K4me3), are enriched near transcription start sites (TSS) in genes (values
denote basepairs relative to the TSS): -900 and +1000 for H3K4me1, -500 and +700 for
H3K4me2, and -300 and +100 for H3K4me3 (Barski et al., 2007; Heintzman et al., 2007).
Histone methyltransferases and demethylases are enzymes that create, maintain, and
erase histone methylation marks. Lysine-specific demethylase 1 (LSD1, also known as
KDM1A, BHC110 and AOF2) is the first histone demethylase that was discovered; it
represses transcription by removing methyl groups from H3K4me1/2 (Shi et al., 2004;
Karytinos et al., 2009). LSD1 is unique among multiple demethylases in that it belongs to
the flavin-containing amine oxidase family and utilizes flavin adenosine dinucleotide
(FAD) as an essential cofactor for catalytic activities (Forneris et al., 2005). FAD,
produced by adenylation of the vitamin riboflavin, serves as a coenzyme in a large
number redox reactions and a small number of reactions with no net redox change in
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mammalian metabolism (Bornemann, 2002; Henriques et al., 2010; Pinto and Rivlin,
2013). LSD1 is enriched in gene promoter regions as part of multiprotein gene repression
complex (Wang et al., 2009; Foster et al., 2010; Whyte et al., 2012). LSD2 (also known
as KDM1B and AOF1), the only mammalian homolog of LSD1, is also a member of the
flavin-containing amine oxidase family. Like LSD1, LSD2 may also catalyze
demethylation through the removal of methyl groups from H3K4me1/2 in an FADdependent reaction (Zhang et al., 2012). Unlike LSD1, LSD2 is enriched in gene regions
other than those adjacent to the TSS and forms protein complexes that regulate gene
expression independent of FAD (Fang et al., 2010; Yang et al., 2010).
Previous studies suggest that stimulation of pro-inflammatory genes causes changes in
histone methylation patterns in promoter regions, consistent with a role of histone
demethylases in the regulation of pro-inflammatory cytokines (Saccani and Natoli, 2002;
El Gazzar et al., 2007; Foster et al., 2007). LSD1 may synergize with histone deacetylase
1 to repress pro-inflammatory cytokines in breast cells and hepatocytes (Janzer et al.,
2012). Studies in diabetic mouse models specifically implicate LSD1 in the regulation of
pro-inflammatory gene expression in vascular smooth muscle cells (Reddy et al., 2008;
Wierda et al., 2010).
It is widely recognized that nutritional factor play a role in methylation events, albeit the
majority of previous studies focused on methyl donors (Zempleni et al., 2012). Here we
tested the hypothesis that LSD1 activity depends on the concentrations of the FAD
precursor, riboflavin, in cell culture media, and that riboflavin deficiency causes derepression of pro-inflammatory cytokines in human T lymphoma Jurkat cells. In addition,
we assessed the distribution of H3K4me2 marks in regions upstream and downstream of
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the TSS in pro-inflammatory genes. Jurkat cells were chosen as model, because
riboflavin homeostasis has been well characterized in this cell line (Camporeale and
Zempleni, 2003) and the cells express the pro-inflammatory cytokines interleukin (IL)-1α,
IL-1β, IL-6, and tumor necrosis factor-α (TNF-α) when stimulated with phorbol esters
(Wano et al., 1987; Khalaf et al., 2010).

Results
Determination of flavin status
Glutathione reductase activity was 23% higher in riboflavin-supplemented Jurkat cells
compared with riboflavin-sufficient cells, and the levels of reduced glutathione were 20%
lower in riboflavin-deficient cells compared with riboflavin-sufficient cells (Fig. 2A).
These observations are consistent with the notion that concentrations of riboflavin in
culture media affected the intracellular flavin status, suggesting that treatment was
effective (Camporeale and Zempleni, 2003).
Expression of LSD1
The expression of LSD1 mRNA was about 57% greater in riboflavin-deficient cells and
24% less in riboflavin-supplemented cells compared with riboflavin-sufficient cells (Fig.
2B). The protein abundance of LSD1 followed a similar pattern (arbitrary units of gel
densitometry): 8.72 ± 0.96 for riboflavin-deficient cells vs. 6.31 ± 0.42 for riboflavinsufficient cells vs. 2.98 ± 0.56 for riboflavin-supplemented cells (p-value < 0.05 for all
possible comparisons; n=3).
LSD demethylase activity
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LSD demethylase activity depended on the concentration of riboflavin in culture media.
LSD activity was 33% greater in riboflavin-supplemented cells compared with riboflavinsufficient cells after 7 days of culture (Fig. 2C). No significant difference was observed
between riboflavin-deficient and sufficient cells.
Enrichment of H3K4me2 activation marks
The abundance of H3K4me2 marks was higher in exon 1 in riboflavin-deficient cells
compared with the other treatment groups. For example, the abundance of H3K4me2
marks was 137%, 49%, and 27% higher in exon 1 in the IL-1α, IL-1β, and IL-6 genes,
respectively, in riboflavin-deficient cells compared with riboflavin-sufficient cells (Fig.
3A-C). Effects were comparably moderate for exon 1 in the TNF-α gene: the enrichment
of H3K4me2 marks in exon 1 of the TNF-α gene was 11% higher in riboflavin-deficient
cells and 17% lower in riboflavin-supplemented cells compared with riboflavin-sufficient
cells (Fig. 3D). In contrast, effects of riboflavin on the abundance of H3K4me2 in the
promoter region, as opposed to exon 1, of the four genes were not biologically
meaningful (Fig. 3A-D).
Expression of pro-inflammatory cytokines
The levels of mRNA coding for pro-inflammatory cytokines were 62-487% greater in
riboflavin-deficient cells compared with riboflavin-sufficient cells (Fig. 4A-D). In
addition, mRNA levels of IL-1α and TNF-α were 12% and 19% lower, respectively, in
riboflavin-supplemented cells compared with riboflavin-sufficient cells (Fig. 4A and D).

Discussion
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This is the first report to implicate riboflavin deficiency in the aberrant up-regulation of
pro-inflammatory cytokines through loss of LSD1 activity. Our observations suggest that
loss of LSD1 demethylase activity specifically affects the abundance of H3K4me2 marks
in exon 1 regions of pro-inflammatory genes whereas the abundance of these marks in
promoter regions was largely unaffected by riboflavin. Although higher LSD1 expression
was observed in riboflavin-deficient cells, this up-regulation was not sufficient to
compensate for the depletion of the flavocoenzyme FAD and holo-LSD1, as judged by
the accumulation of H3K4me2 activation marks and increased pro-inflammatory gene
expression in riboflavin-deficient cells.
This paper has important implications for human health. Inflammation plays roles in
diseases that affect a large percentage of the population, e.g., arthritis and inflammatory
bowel disease. For example, 22% of U.S. adults suffer from doctor-diagnosed arthritis,
and 9% have arthritis-attributable activity limitations (Centers, 2010). Evidence suggests
that pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, produced by synovial cells and
infiltrating cells, actively participate in synovitis and joint destruction and have been
linked with rheumatoid arthritis (Arend and Dayer, 1995; Brennan and McInnes, 2008;
Corvaisier et al., 2012).
LSD1, rather than LSD2, mediates the effects of riboflavin deficiency on gene expression.
Although peptide demethylation assays cannot distinguish between the two LSD
homologs, previous studies demonstrate that LSD2 specifically associates with the
coding region of its target genes where it synergizes with euchromatic histone
methyltransferases EHMT1/2 and NSD3 in the regulation of transcriptional elongation
(Fang et al., 2010). In addition, LSD2 may repress genes through its LSD2-specific Zf-
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CW domain (Yang et al., 2010), suggesting that LSD2 may be functional in states of
riboflavin deficiency.
A few uncertainties remain and need further investigation. First, we did not assess the
actual binding of LSD1 around TSS, based on the rationale that such studies would need
to be performed using ChIP assays and antibodies that distinguish between apo- and the
holo-LSD1. No such antibodies are currently available. Second, the impaired H3K4me2
demethylation in riboflavin-deficient cells might be rescued by FAD-independent histone
demethylases, such as H3K4me2 demethylases JARID1A, JARID1B, JARID1C, and
JARID1D, which belong to Jumonji AT-rich interactive domain subfamily of Jumonji C
domain containing proteins (Christensen et al., 2007; Iwase et al., 2007; Klose et al.,
2007; Lee et al., 2007; Tahiliani et al., 2007; Yamane et al., 2007).
Future work is required to determine the underlying mechanism of LSD1-mediated
repression of pro-inflammatory cytokines by riboflavin and its implication in human
health. A logical next step would be to assess effects of riboflavin deficiency in a mouse
feeding study.

Materials and Methods
Cell cultures
Human T lymphoma Jurkat cells (ATCC, Manassas, VA, USA) were cultured in
riboflavin-defined RPMI-1640 medium (HyClone, Logan, UT, USA) as described
previously (Camporeale and Zempleni, 2003; Manthey et al., 2006). Riboflavin
concentrations in the culture media were adjusted to 3.1 nmol/L (denoted deficient,
“DEF”), 12.6 nmol/L (denoted sufficient, “SUF”), and 301 nmol/L (denoted
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supplemented, “SUP”), taking into account the residual concentrations of riboflavin,
flavin mononucleotide (FMN), and FAD in dialyzed fetal bovine serum. Cells were
cultured in riboflavin-sufficient medium for 7 days before transfer into the riboflavindefined and continued culture for 7 days before analysis. This protocol was chosen based
on previous and preliminary studies suggesting abnormally slow cell growth after 10 days
of culture in riboflavin-deficient media (Manthey et al., 2005; Werner et al., 2005). The
production of pro-inflammatory cytokines was induced by treatment with 100 μg/L
phorbol 12-myristate 13-acetate (PMA) for 8 h before analysis (Khalaf et al., 2010). Cells
cultured in riboflavin-sufficient medium were designated as the control group.
Glutathione metabolism
The activity of glutathione reductase and the level of reduced glutathione were used as
markers of FAD status in Jurkat cells (Camporeale and Zempleni, 2003; Manthey et al.,
2006). After 7 days of culture in riboflavin-defined media, Jurkat cells were harvested
and lysed for assessment of glutathione metabolism. Glutathione reductase activity was
quantified in cell lysates containing 0.5 mg protein as described previously (Sauberlich et
al., 1972). One unit of glutathione reductase activity is presented by the change of
absorbance at 340 nm per 0.5 mg protein in 10 min of incubation. The concentration of
reduced glutathione in lysates was determined colorimetrically using the 5,5-dithiobis(2nitrobenzoic acid) reduction assay as described previously (Tietze, 1969). The assay was
calibrated using chemically pure reduced glutathione.
Western blot analysis
Expression of LSD1 protein was quantified by western blot as described previously
(Manthey et al., 2006), using rabbit polyclonal anti-human LSD1 (Abcam, Cambridge,
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MA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was probed using
mouse monoclonal anti-human GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and used as loading control. Data were quantified by gel densitometry analysis.
LSD demethylase activity
The assessment of LSD demethylase activity was conducted in Jurkat cells after 7 days of
culture in riboflavin-defined media with demethylase (LSD-type) activity assay kit
(Cayman Chemical, Ann Arbor, MI, USA) according to the manufacturer’s instructions.
One unit of LSD activity is defined as the ratio of sample fluorescence to background
fluorescence. This assay does not distinguish between the two LSD in the human
proteome, LSD1 and LSD2 (Culhane and Cole, 2007).
Chromatin immunoprecipitation (ChIP) assay
The enrichment of H3K4me2 marks near the TSS of human pro-inflammatory genes such
as IL-1α, IL-1β, IL-6, and TNF-α was assessed by ChIP assay as described previously
(Dahl and Collas, 2008). Immunoprecipitations were performed with specific antibodies
to H3K4me2 (Abcam), H3 (Abcam), and rabbit IgG (Santa Cruz Biotechnology). Nuclear
chromatin extracts without immunoprecipitation were used as input control. Precipitation
of chromatin with non-specific rabbit IgG was used as negative control and produced
signals less than 10% compared with those produced by target-specific antibodies.
Precipitations with H3 antibody were used to normalize for H3K4me2 occupancy in proinflammatory genes.
Quantitative real-time PCR (qRT-PCR)
The abundance of mRNA coding for LSD1 and pro-inflammatory cytokines was
quantified by qRT-PCR using Power SYBR Green PCR Master Mix (Applied
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Biosystems, Carlsbad, CA, USA) as described previously (Gralla et al., 2008). The
relative amount of each gene was normalized using housekeeping gene GAPDH.
Amplicons from ChIP assays were analyzed using the PerfeCTa SYBR Green FastMix
(Quanta Biosciences, Gaithersburg, MD, USA) as described previously (Pestinger et al.,
2011). The relative occupancy of H3K4me2 in pro-inflammatory gene regulatory regions
was calculated as described previously (Wei et al., 2006) and values are reported as the
percent of input DNA. To investigate the enrichment of H3K4me2 marks surrounding the
TSS of genes coding for pro-inflammatory cytokines, primers were designed to amplify
sequences upstream (denoted “promoter”) or downstream (denoted “exon 1”) of the TSS
(Fig. 1), using ChIP samples as template (Barski et al., 2007; Heintzman et al., 2007)
(Table 1).
Statistical analysis
Data exhibited normal distributions and homogenous variances, as assessed by
Komolgorov-Smirnov normality test and Bartlett's test, respectively. Statistical
significance was assessed by one-way ANOVA and Fisher’s protected least significant
difference posthoc test (Institute, 1998). StatView 5.0.1 (SAS Institute, Cary, NC) was
used to perform all calculations. Differences were considered significant if p-value <
0.05. Data are expressed as means ± S.D.
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Table 3.1 Oligonucleotide primers used for qRT-PCR
Gene1
GAPDH
GAPDH
IL-1α
IL-1α (-319 to -56)
IL-1α (+128 to +416)
IL-1β
IL-1β (-235 to -67)
IL-1β (+127 to +338)
IL-6
IL-6 (-279 to -93)
IL-6 (+132 to +398)
LSD1
TNF-α
TNF-α (-399 to -192)

Sequence (5’-3’)

F/R2

TCCACTGGCGTCTTCACC

F

GGCAGAGATGATGACCCTTT

R

ATGACAAGCATGAGGCAGAG

F

CAACCAGGACCGTTAACCCTTTCT

R

ACAAAAGGCGAAGAAGACTGA

F

GGAACTTTGGCCATCTTGAC

R

CCAACTCACACAAGCTGCTTT

F

GGTGGTAGAACACCAGACTCTT

R

CTTCTTCTACAGAAGACACACCTT

F

CTGAAGAGGGAAGTTTGCTTGATT

R

CTGTCCTGCGTGTTGAAAGA

F

TTGGGTAATTTTTGGGATCTACA

R

ATATTTGCATGGTGATACATTTGC

F

CTCTGTTGAATACCTGATTTCACAA

R

GCCTCTTTGTGTGTATGCATATT

F

GAGAGCTGGAGCAGAGGCTT

R

TCCAGAACAGATTTGAGAGTAGTG

F

GCATTTGTGGTTGGGTCAGG

R

CTTCGTGCATGACTTCAGCTTT

F

GATTGTGCAATGTGACGTCCTTT

R

CACAAGTAAGTGCAGGAAATCCTT

F

CGGCTACATCTTTGGAATCTT

R

ACCACAACAGACCCAGAAGG

F

GGTGCTTCTAATTGTTGGAGAG

R

GCTCTTCTGCCTGCTGCACTT

F

GATGGCACCACCAGCTGGTT

R

CCTGCATCCTGTCTGGAAGTT

F

GGGACACACAAGCATCAAGGAT

R

TNF-α (+103 to +374) GCTGCCAGGCAGGTTCTCTT

F

Template
cDNA
gDNA
cDNA
gDNA
gDNA
cDNA
gDNA
gDNA
cDNA
gDNA
gDNA
cDNA
cDNA
gDNA
gDNA

96

1

GGCCAGGCACTCACCTCTT
R
Genbank entries: GAPDH = Homo sapiens glyceraldehyde-3-phosphate dehydrogenase

(NM_002046.4 for complementary DNA, NG_007073.2 for genomic DNA); IL-1α =
Homo sapiens interleukin-1 alpha (NM_000575.3 for complementary DNA,
NG_008850.1 for genomic DNA); IL-1β = Homo sapiens interleukin-1 beta
(NM_000576.2 for complementary DNA, NG_008851.1 for genomic DNA); IL-6 =
Homo sapiens interleukin-6 (NM_ NM_000600.3 for complementary DNA,
NG_011640.1 for genomic DNA); LSD1 = Homo sapiens lysine (K)-specific demethylase
1 (NM_001009999.2); TNF-α = Homo sapiens tumor necrosis factor-alpha
(NM_000594.3 for complementary DNA, NG_007462.1 for genomic DNA).
2

Abbreviations: cDNA, complementary DNA (for gene expression analysis); F, forward;

gDNA, genomic DNA (for ChIP assays); R, reverse.
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Figures and legends

Figure 3.1 Schematic of the region adjacent to the TSS in pro-inflammatory genes.
Primers for were designed to amplify sequences upstream (“promoter”) or downstream
(“exon 1”) of the TSS, respectively, in ChIP assays.
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Figure 3.2 Glutathione metabolism (A), LSD1 expression (B), and LSD demethylase
activity (C) depend on the concentrations of riboflavin in Jurkat cell culture media. The
insert depicts a representative immunoblot of LSD1 protein. Values are means ± SD, n=3.
a,b,c

Means not sharing a common letter are significantly different for the same variable, p-

value < 0.05. DEF, deficient; SUF, sufficient; SUP, supplemented.
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Figure 3.3 Enrichment of H3K4me2 marks in IL-1α (A), IL-1β (B), IL-6 (C), and TNF-α
(D) gene promoter and exon 1. Values are means ± SD, n=5. a,bMeans not sharing a
common letter are significantly different for the same variable, p-value < 0.01. DEF,
deficient; SUF, sufficient; SUP, supplemented.
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Figure 3.4 The expression of IL-1α (A), IL-1β (B), IL-6 (C), and TNF-α (D) mRNA
depends on the concentrations of riboflavin in Jurkat cell culture media. Values are
means ± SD, n=3. a,b,cMeans not sharing a common letter are significantly different for
the same variable, p-value < 0.05. DEF, deficient; SUF, sufficient; SUP, supplemented.
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OUTLOOK

We have demonstrated that HLCS plays an important role in gene regulation through the
formation of multi-protein repression complex in human chromatin. Although several
possible members of this complex have been identified and well characterized in cell
cultures, a conditional HLCS knockout (KO) mouse model will allow us to validate
previous in vitro observations and perform animal studies that are currently not feasible.
Non-conditional KO mice are likely not viable based on observations that there is no
living HLCS null individual. We are in the process of creating a conditional HLCS KO
mouse in which expression can be controlled both spatially and temporally. These mice
will allow us to knock out HLCS gene in specific tissues at defined developmental stages
and investigate the impacts of HLCS on gene regulation and genome stability under
controlled conditions.
We observed that LSD1 mediates gene repression through epigenetic mechanisms that
depend on sufficient riboflavin supply. Riboflavin deficiency has been documented in
industrialized and developing nations and across various demographic groups, e.g.,
pregnant women, infants, and the elderly (National, 1998; Powers, 2003). Diseases such
as cancer, cardiac disease, and diabetes mellitus have been linked with riboflavin
deficiency (Cole et al., 1976; Steier et al., 1976; van Rensburg, 1981; Foy and Kondi,
1984; Liu et al., 1993). These disease models should be assessed in the light of aberrant
LSD1 activity. In addition, future studies will need to assess effects of riboflavin
deficiency on inflammatory processes, considering that we observed an aberrantly high
expression of inflammatory cytokines in cell cultures.
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APPENDIX
--- Raw data for each chapter
Table 1 (Chapter I) Split luciferase complementation assays for detection of HLCS and
N-CoR or HDAC1s interaction in HEK293 cells.
Luciferase activity ratio (arbitrary units)

Fusion constructs

1

2

3

HLCS-NLuc+N-CoR-NT-CLuc

2.231

2.577

2.644

HLCS-NLuc+N-CoR-CD-CLuc

2.332

2.691

3.219

HLCS-NLuc+N-CoR-CT-CLuc

10.094

12.725

12.853

HLCS-NLuc+HDAC1-CLuc

8.229

10.628

9.420

HLCS-NLuc+HDAC1Δ31-CLuc

8.355

9.737

9.383

NLuc+CLuc

2.836

3.631

3.157

TP53-NLuc+MDM2-CLuc

7.748

8.391

9.805

TP53-NLuc+CDK3-CLuc

3.047

4.326

4.316

Table 2 (Chapter I) The enrichment of H3K9ac marks in loci coding for repeats and
GAPDH in HLCS overexpression HEK293 cells and controls.
Cell lines

Gene loci

FLAG/Myc-HLCS

RT-PCR Ct values normalized by H3 and input
1

2

3

LTR15

0.0528

0.0531

0.0545

Control

LTR15

0.1050

0.1083

0.1093

FLAG/Myc-HLCS

LTR22

0.3198

0.2877

0.3179

Control

LTR22

0.9610

0.9876

0.9598

FLAG/Myc-HLCS

Chr1apha

0.0093

0.0094

0.0098

Control

Chr1apha

0.0244

0.0248

0.0254

FLAG/Myc-HLCS

Chr4apha

0.0251

0.0261

0.0260

Control

Chr4apha

0.0496

0.0513

0.0528

FLAG/Myc-HLCS

GAPDH

0.7652

0.7054

0.7346

Control

GAPDH

0.7143

0.7049

0.7391
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Table 3 (Chapter I) The abundance of transcripts coding for HLCS, LTRs, Chr1alpha,
and Chr4alpha in HLCS overexpression HEK293 cells and controls.
Cell lines

Gene loci

FLAG/Myc-HLCS

RT-PCR Ct values normalized by GAPDH
1

2

3

HLCS

48.889

45.384

53.521

Control

HLCS

0.987

1.023

0.990

FLAG/Myc-HLCS

U5

0.181

0.175

0.165

Control

U5

0.991

1.011

0.998

FLAG/Myc-HLCS

R-U5

0.142

0.152

0.213

Control

R-U5

1.016

1.105

0.891

FLAG/Myc-HLCS

Chr1apha

0.215

0.194

0.173

Control

Chr1apha

1.107

0.878

1.029

FLAG/Myc-HLCS

Chr4apha

0.183

0.164

0.193

Control

Chr4apha

0.944

0.978

1.084
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Table 4 (Chapter II) Effects of riboflavin concentrations in HepG2 cell culture media on
glutathione reductase activity.
Riboflavin

Glutathione reductase activity [A340/(0.5 mg protein x 10 min)]
1

2

3

Deficient

0.211

0.198

0.191

Sufficient

0.225

0.211

0.205

Supplemented

0.351

0.319

0.343

Table 5 (Chapter II) Effects of riboflavin concentrations in HepG2 cell culture media on
reduced glutathione concentration.
Riboflavin

Reduced glutathione concentration (ug/2mg protein)
1

2

3

Deficient

49.733

51.067

50.867

Sufficient

59.267

60.000

60.867

Supplemented

60.733

61.533

62.200

Table 6 (Chapter II) Effects of riboflavin concentrations in HepG2 cell culture media on
LSD demethylase activity.
Riboflavin

LSD demethylase activity (arbitrary units)
1

2

3

Deficient

2.877

3.800

3.610

Sufficient

3.384

3.850

4.182

Supplemented

4.479

4.538

4.792
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Table 7 (Chapter II) Effects of riboflavin concentrations in HepG2 cell culture media on
expression of LSD1 and albumin mRNA.
RT-PCR Ct values normalized by GAPDH
LSD1

Riboflavin

Albumin

1

2

3

1

2

3

Deficient

1.237

1.315

1.293

2.925

3.047

3.101

Sufficient

1.021

0.998

0.981

0.940

0.977

1.089

Supplemented

1.072

1.019

0.901

0.944

0.842

1.093

Table 8 (Chapter II) Effects of riboflavin concentrations in HepG2 cell culture media on
the enrichment of LSD1, H3K4me2, and H3K9me3 in the albumin promoter.

Riboflavin

RT-PCR Ct values
normalized by H3 and
input
LSD1
1

2

3

Deficient

1.257

1.306

1.561

Sufficient

0.905

0.585

0.612

Supplemented

0.896

0.486

0.768

RT-PCR Ct values normalized by H3 and input
Riboflavin

H3K4me2

H3K9me3

1

2

3

1

2

3

Deficient

3.502

3.386

3.327

0.337

0.299

0.302

Sufficient

1.255

1.235

1.213

0.485

0.519

0.500

Supplemented

1.042

1.063

1.017

0.468

0.469

0.531
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Table 9 (Chapter III) Effects of riboflavin concentrations in Jurkat cell culture media on
glutathione reductase activity.
Riboflavin

Glutathione reductase activity [A340/(0.5 mg protein x 10 min)]
1

2

3

Deficient

0.210

0.213

0.189

Sufficient

0.227

0.215

0.208

Supplemented

0.274

0.252

0.271

Table 10 (Chapter III) Effects of riboflavin concentrations in Jurkat cell culture media on
reduced glutathione concentration.
Riboflavin

Reduced glutathione concentration (ug/mg protein)
1

2

3

Deficient

26.133

26.200

26.667

Sufficient

32.633

32.467

33.233

Supplemented

32.700

33.133

33.300

Table 11 (Chapter III) Effects of riboflavin concentrations in Jurkat cell culture media on
LSD demethylase activity.
Riboflavin

LSD demethylase activity (arbitrary units)
1

2

3

Deficient

3.532

3.086

3.791

Sufficient

3.304

3.032

4.121

Supplemented

5.051

4.258

4.571
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Table 12 (Chapter III) Effects of riboflavin concentrations in Jurkat cell culture media on
the expression of LSD1 and pro-inflammatory cytokine mRNA.
RT-PCR Ct values
normalized by GAPDH
Riboflavin

LSD1
1

2

3

Deficient

1.011

1.009

0.980

Sufficient

0.640

0.636

0.638

Supplemented

0.481

0.482

0.485

RT-PCR Ct values normalized by GAPDH
Riboflavin

IL-1α

IL-1β

1

2

3

1

2

3

Deficient

1.021

0.998

0.981

1.065

1.067

0.880

Sufficient

0.644

0.557

0.559

0.158

0.158

0.199

Supplemented

0.516

0.544

0.484

0.072

0.094

0.087

RT-PCR Ct values normalized by GAPDH
Riboflavin

IL-6

TNF-α

1

2

3

1

2

3

Deficient

0.868

1.248

0.923

1.008

1.028

0.965

Sufficient

0.613

0.560

0.698

0.514

0.509

0.454

Supplemented

0.450

0.491

0.460

0.438

0.394

0.379
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Table 13 (Chapter III) Effects of riboflavin concentrations in Jurkat cell culture media on
the enrichment of H3K4me2 marks in pro-inflammatory gene promoter and exon 1.

Riboflavin

RT-PCR Ct values normalized by H3 and input
1

2

3

4

5

Deficient

0.284

0.209

0.297

0.218

0.198

promoter Sufficient

0.180

0.187

0.136

0.168

0.171

Supplemented

0.205

0.193

0.205

0.209

0.283

Deficient

2.781

2.208

2.700

1.830

2.061

Sufficient

0.755

1.141

0.983

0.871

1.146

Supplemented

0.852

0.909

1.207

0.947

0.892

Deficient

0.353

0.415

0.431

0.374

0.381

promoter Sufficient

0.321

0.317

0.377

0.297

0.343

Supplemented

0.326

0.378

0.375

0.377

0.405

Deficient

0.832

0.949

0.950

0.888

0.890

Sufficient

0.637

0.597

0.589

0.613

0.599

Supplemented

0.554

0.569

0.638

0.621

0.532

Deficient

1.344

1.323

1.308

1.306

1.349

promoter Sufficient

1.122

1.158

1.121

1.234

1.371

Supplemented

1.224

1.147

1.219

1.211

1.304

Deficient

13.038

12.132

13.297

11.319

13.757

Sufficient

10.049

8.397

9.809

11.030

10.763

Supplemented

9.075

10.295

9.922

9.235

9.129

Deficient

0.230

0.195

0.249

0.215

0.285

promoter Sufficient

0.179

0.149

0.208

0.141

0.153

Supplemented

0.232

0.214

0.189

0.239

0.230

Deficient

16.539

16.152

15.795

15.904

15.688

Sufficient

14.514

15.272

15.172

12.712

14.425

Supplemented

11.805

11.845

12.271

11.942

11.720

IL-1α
exon 1

IL-1β
exon 1

IL-6
exon 1

TNF- α
exon 1

